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Aorta 
The main blood vessel that carries oxygenated blood away from the heart to the body 
 
Vein 
Blood vessels that transport oxygen-poor but, pulmonary blood away from the body 
towards the heart 
 
Artery 
Blood vessels that carry oxygen but, pulmonary blood away from the heart to the body 
 
Angina 
Severe constricting pain that patients with heart disease often experience (e.g. when over-
exerting themselves) 
 
Angiogram 
Radiographic image of blood vessels in a living patient 
 
Angioplasty 
Procedure to open blocked blood vessel 
 
Atherosclerosis 
-Multi stage process 
Hardening of change overtime sized arteries (characteristically irregular distribution of 
lipid deposits in arterial intima. Then deposits are covered within fibrous cap.  
 
Calcification 
Deposition of calcium. in the arterial wall 
 
Stenosis 
Blockage, obstruction, or narrowing of the arteries 
 
Hemorrhage 
Bleeding  
 
Thrombosis 
Formation of blood clots inside of a blood vessel 
 
Lymphocytes  
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Endothelium 
The endothelium is located at the interface between the blood and the vessel wall 
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Osteonectin 
A protein that plays role in mineralization of covalently binds bone 
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A bone matrix protein 
 
Matrix Gla protein (MGP) 
The protein controls the formation and the restoration of bone. The protein has strong 
affinity for calcium binding and can be crystallized in the form of hydroxyapatite.  
 
Raised lesion 
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fibrous cap and the atheroma. 
 
Fibrous cap 
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Atheroma 
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fatty materials, but sometimes is used to describe advanced plaque deposits with lesions. 
 
Fatty streak 
Flat or slightly elevated lesions that contain intracellular and extracellular lipids in 
intima.  Fatty streaks are localized in the early stages of atherosclerosis 
 
Crystalline deposits or hard plaques 
Mass of organic and inorganic materials in the crystalline phase of the plaque deposits  
 
Soft plaque 
Smooth and fatty deposits, sometimes called amorphous plaque 
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Terms Used in Pathology to Define the Types of Human Atherosclerotic Plaque 
Lesions  
 
PLAQUES 
 
Atherosclerotic 
Lesions 
Lesions Defined Based on 
Appearance 
 
Type I 
 
Initial lesion 
 
  
 
Type II 
 
Progression-prone type II 
lesion 
Progression-resistant type II 
 
Fatty dot or streak 
 
Early lesions 
 
Type III 
 
Intermediate lesion 
(preatheroma) 
  
 
Type IV 
 
 
Atheroma 
  
Atheromatous 
plaque, fibrolipid 
plaque, fibrous 
plaque, plaque 
 Type V Fibroatheroma (type V 
lesion) 
Calcific lesion (type VII 
lesion) 
Fibrotic lesion (type VIII 
lesion) 
Calcified plaque 
 
Fibrous plaque 
 
Advanced lesions, 
raised lesions 
Type VI Lesion with surface defect, 
and/or hematoma-
hemorrhage, and/or 
thrombotic deposit 
Complicated lesion, 
complicated plaque 
 
 
(1998 American Heart Association) 
 
 
 
ABSTRACT 
 Gradual deposits of lipids, proteins, and calcium on the coronary arterial walls 
cause atherosclerosis, leading to blockage of the blood flow and possible heart attack.  
Despite many studies, the mechanism underlying these processes remains unclear.  In this 
research, differences between native and bypass plaque deposits from the same heart 
were examined.  In addition, the crystalline and the amorphous plaques within these 
native and bypass vessels were characterized.  The techniques used to characterize the 
deposits included inductively coupled plasma mass spectrometry (ICPMS), solid-state 
nuclear magnetic resonance (NMR), high performance liquid chromatography (HPLC), 
etc. 
 The results from the ICPMS technique showed that the concentrations of Ca and 
P varied widely in the bypass arteries.  In contrast, the concentrations of Ca and P were 
higher in the native deposits.  The molar ratios of Ca/P indicated that these elements 
probably exist as hydroxyapatite in the calcified tissues.  However, the molar ratio of 
Ca/P in the soft tissue suggests that the phosphorus does not only exist as hydroxyapatite 
but that at least half of it may also be organic.   
The 13C and 31P solid-states NMR spectra of the native and bypass coronary 
plaques from the same heart indicated that the concentrations of carbonyl groups, typical 
of cholesterol esters, were similar between the native and bypass arteries.  Significant 
signals of carbonyl groups in the crystalline and amorphous plaques were due to amino 
acids and proteins deposited in the plaques.  Studies of 31P showed that the phosphorus 
exists mostly as hydroxyapatite in the crystalline native plaque, but a large proportion 
exists as organic phosphorus.  
 xvii
 xviii
To study the interactions of calcium with homocysteine and cholesterol, 13C solid-
state NMR of homocysteine, Ca-homocysteine, Ca-homocysteine-cholesterol, Ca-
cholesterol were performed.  Significant spectral changes were also noted when calcium 
was added to homocysteine and cholesterol.   
The chemical forms and the distribution of calcium were studied using x-ray 
absorption and light microscopy with silver staining.  Finally, chromatographic methods 
(CEC and APCI-MS) showed that only 40 % or less of the plaque in native or bypass 
arteries consisted of cholesterol and its esters and the remaining, 60% were composed of 
proteins, fatty acids, and phospholipids.   
 
CHAPTER 1 
INTRODUCTION 
Part I. Background on Atherosclerosis 
Atherosclerosis 
 
The accumulations of organic and inorganic materials in human coronary arteries 
result in the formation of plaque deposits.  Over time plaques continue to deposit on the 
arterial wall reducing the artery diameter.  Thus, there is a decrease in the blood flow, 
which may eventually cause a heart attack or stroke.  This process of plaque formation is 
called atherosclerosis [1-9].  However, the mechanism responsible for plaque formation 
is not well understood.  Figure 1.1A shows a cross section of a normal artery.  The blood 
flows through the lumen.  Then, plaque deposition starts to occur due to the dysfunction 
of the endothelium of the arterial walls.  Then lipoproteins become trapped in the arterial 
wall, and monocytes, and lymphocytes adhere to the artery surface.  Eventually, the 
structural formation of the plaque deposits involves the lymphocytes forming initial 
lesions known as fatty streaks (Figure 1.1B).  Fatty streaks are deposits of intracellular 
(foam cells) and extracellular lipids found in the intima.  Gradually in the connective 
tissue, smooth muscle cells form, which include fiber proteins, collagen, and 
proteoglycans.  Over time the cell components diffuse leading to the transformation of 
monocytes to macrophages.  In the later stage of the disease, more lipids and cholesterol 
(free and esterified cholesterol) continue to accumulate on the arterial wall (Figure 
1.1C).  In summary, the lesions in the early stages are known as fatty streaks and the later 
stages are known as fibrous plaques [1-9].   
 
 1 
 Figure 1.1  A)  Cross section cut of a normal artery.  B) Early stage of 
atherosclerotic plaque deposits.  There is a proliferation of smooth 
cells; and presence T cells platelets, and leucocytes.  These events 
are indicators of atherosclerosis.  C) Schematic of advanced 
deposits with accumulation necrotic core, necrotic caps, and 
macrophages [2]. 
 
There is a growing consensus that molecules, other than cholesterol, may enhance 
the plaque formation, destabilize the existing plaques, or trigger inflammation and 
degeneration of the arterial walls [10-17].  These advanced plaques have been associated 
with high levels of cholesterol, cholesteryl esters and calcium [6-10].  For example, 
Hirsch et al. revealed that in human atherosclerotic lesions, unesterified cholesterol and 
calcium phosphate, in the form of hydroxyapatite, are in close proximity to each other 
within the same plaque deposit [18].  Currently, it is not obvious whether cholesterol 
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induces calcium deposition or vice versa, because in advanced plaque deposits, calcium 
complexes and cholesterol derivatives are present in large crystalline aggregates [18].   
Risk Factors 
Homocysteine, an amino acid, when present in the blood contributes to 
endothelium damage, harms smooth muscle of the arterial walls, and enhances plaque 
formation.  In 1969, McCully proposed that the homocysteine concentrations in the blood 
are proportional to the risk of heart disease [19].  To explain the cause of injuries in the 
arterial walls, Wang, et al. elaborated on McCully’s homocysteine medical hypothesis 
[20].  Wang’s hypothesis indicates that a high presence of homocysteine in the blood 
enables the formation of calcium/homocysteine related products [20].  High 
concentrations of homocysteine in the blood favor interactions with calcium ions of the 
calcium-dependent cell junction [20].  The calcium/homocysteine interaction causes 
structure dissociation, which can damage the vascular endothelium.  The levels of 
homocysteine in the body are influenced by diet, smoking, genetics, drugs, menopause, 
exercise, and blood pressure [21-23].   
Exposure to tobacco smoke also has a detrimental effect on heart disease [24-26] 
by enhancing lesion formation.  It is believed that free radicals in cigarette smoke cause 
oxidation of lipids [27].  Previous studies comparing the susceptibity of lipid 
peroxidation in smokers and non-smokers have been inconsistent [27].  One explanation 
is the dietary difference between smokers and non-smokers.  The dietary and serum 
levels of antioxidants are lower in smokers than nonsmokers.  Hence, the susceptibility of 
lipid peroxidation in smokers depends on the levels of serum antioxidants.  Miller et al. 
demonstrated that cigarette smokers have higher degrees of lipid peroxidation than 
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nonsmokers [30,31].  In addition, the Pathobiological Determinant Research Group 
concluded that the serum thiocyanate concentration, a marker for smoking, was found in 
high concentrations in plaque deposits.   
The body naturally produces cholesterol for cell function, and lipoproteins assist 
in the transportation of cholesterol into the blood stream.  Lipoproteins include very low-
density lipoprotein (VLDL), intermediate density lipoprotein (IDL), low-density 
lipoprotein, and high-density lipoprotein (HDL).  These lipoproteins have very complex 
structures where the protein portion can be very diverse in structure and the lipid portions 
have the composition of cholesterol and cholesteryl esters.  HDL and LDL are the most 
important lipoproteins because of their roles in the biological system.  HDL, the so-called 
“good” cholesterol, primarily transfers cholesterol back to the liver where it is 
transformed into bile acids.  However, LDL transports cholesterol from the liver to the 
rest of the body and helps to facilitate lipid uptake by the cells.  When LDL is degraded 
in the cells, the protein portion is hydrolyzed to cholesterol and fatty acids to supply the 
cellular membranes.   The excess of cholesterol is then stored as cholesteryl oleate or 
cholesteryl palmitate.  These esters are synthesized by the process of acyl-CoA 
cholesterol acytransferase (ACAT), which is enhanced by the presence of free cholesterol 
[1, 32]. 
Calcification of the Arterial Wall 
Vascular calcification is associated with the deposition of calcium phosphate 
complexes (especially hydroxyapatite) in coronary tissues.  It is well established that 
calcification is one of the main characteristics of advanced atherosclerosis.  Calcium 
deposits in the arterial walls can be enhanced when the patient is diabetic or has some 
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renal dysfunction.  Recent studies have revealed that calcification is considered to be the 
final stage of atherosclerosis progression [6-8].  Despite studies that are involved in the 
characterization of complex proteins associated with vascular calcification, such as 
osteopontin, osteonectin, esteocalcin, and matrix Gla protein (MGP), the mechanism 
controlling the calcification of tissues remains unclear.  However, there is some evidence 
that serum phosphate levels are linked to calcification of tissues. Clinical studies have 
shown that phosphate serum levels at higher-than-normal concentrations (1.0 to 1.5 
mmol/L) correlate with vascular calcification.  In those cases, most of the vascular 
calcification occurs as a result of a mineral imbalance. Giachelli, et al, tested this 
hypothesis by monitoring the mechanism controlling vascular calcification [33,34].  Their 
finding suggested that human aortic smooth cells (HSMC) calcification was controlled at 
least in part through a sodium-dependent phosphate transport-sensitive process. This kind 
of procedure characterized the response of HSMC after they had been exposed to high 
phosphorus levels. 
Over the years, calcium and vitamin D have been prescribed to enhance 
deposition of calcium in bones.  However, the intake of the osteoregulatory molecules 
may also have an impact on the calcium deposition in vascular walls [35]. To assess the 
potential of osteo-regulation on the development of vascular calcification, Watson, et al. 
investigated the vitamin D levels in serum in association with vascular calcification [35].  
They found that vitamin D was inversely correlated with the progression of vascular 
calcification in both populations.  Furthermore, no correlation was found between the 
extent of calcification and levels of osteocalcium and parathyroid hormones.   
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Proposed Treatments of Blocked Arteries 
Atherosclerotic blockages of the coronary arteries can cause angina or heart 
attacks.  Usually, when the medication or the changes of lifestyle (diet, exercise, and 
smoking) do not improve the heart health, the physician may recommend angioplasty or a 
coronary artery bypass surgery. Due to the risks of these medical interventions, doctors 
reserve angioplasty or bypass operation for patients who do not derive the maximum 
benefit from medication [36,37].   
In coronary angioplasty, a catheter with a small balloon on the tip is inserted into 
an artery either in the groin or the arm.  Then, the catheter is pushed into the coronary 
arteries and the balloon tip is enlarged in order to open the blockage.  This procedure is 
called percutaneous transluminal coronary angioplasty (PTCA).  PTCA is not very 
efficient for removing serious blockages [36,37]. Bypass surgery is an alternative 
procedure to treat blocked arteries.  Coronary artery bypass grafting involves the removal 
of a healthy saphenous vein from the leg of the patient for use as the bypass artery.  One 
end of that vein is connected to the aorta, near the origin of the blocked coronary artery. 
[36-39].   Then, the other end is connected to the lower end of the same coronary artery.  
A similar bypass procedure can be performed using the internal mammary arteries instead 
of the saphenous veins. Figure 1.2 is an illustration of a bypassed artery around the 
blockage.   
Although surgery may improve the heart conditions of patients, it is not clear why 
about 40% of people who had bypass operations show symptoms of a new blockage 
either in the bypass grafts or in another coronary artery within 10 years of the operation.  
Furthermore, complications such as angina or death can occur in people with coronary 
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bypass grafts [37-39].  Because of all the risks that can occur during or after the 
operation, it is crucial to gain more understanding of the formation mechanism of the 
coronary artery blockages.   
 
 
Figure 1. 2 Illustration of two bypassed arteries around the blockages [36]. 
 
Part II.  Background on the Analytical Methods Used in this Dissertation 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) 
Inductively coupled plasma mass spectrometry (ICP-MS) determines the 
concentrations of trace metals [40-43].  ICP-MS provides minimum interferences and can 
be applied in a wide range of studies.  In addition, ICP-MS can be coupled with 
separation instruments, such as high performance liquid chromatography (HPLC), 
capillary electrophoresis (CE), and capillary electrochromatography (CEC).  While ICP-
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MS is not the only available technique for metal analysis, it is sensitive to a wide group 
of metals.   
Inductively Coupled Plasma (ICP) Source 
Plasma is an electrically neutral gas, which is composed of free moving electrons 
and ions [40-48].  A monatomic gas in a plasma state can be described by use of the 
following equation [40-48]   
X X n en
n
q
n
q
= ++
=
−
=
∑ ∑
1 1
( ) ,     (1.1) 
where Xn+ is the ionic form with n charges and e- the charge of an electron.   
 
Figure 1.3 A) Inductively coupled plasma source.  B) Inductively coupled plasma 
torch. 
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For ICP, plasma is generated when argon flows through a radio frequency field.  
Then, the argon plasma passes through a quartz tube, which has a 1 to 25 kW radio 
frequency power source.  Figure 1.3 has a schematic of an ICP torch [48].  When the 
sample atoms reach the top of the source, they are exposed at temperatures ranging from 
4000 to 8000 K.  These temperatures are enough to allow complete atomization and 
ionization interference effects.  The ionization of the plasma gas is ionized when 
electrons and the argon molecules collide [46-70], i.e., 
                          ,                    (1.2) e Ar Ar e e− + −+ = + + −
where Ar is the argon molecule, Ar+ is the argon ion, and e- is the charge of an electron. 
Then, through a recombination of processes, argon ions recombine with electrons to form 
an excited argon molecule, Ar* [46-70], i.e., 
e Ar Ar h− ++ = +* υ                                     (1.3) 
Finally, analytes are ionized as a result of electronic interaction between species in the 
plasma.  Then, analyte ions are measured using mass spectrometry. 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) 
In ICP-MS, samples are injected into the center of the plasma as aerosols.  The 
ICP plasma source dissociates the sample into its elemental composition.  Then, the ions 
migrate into the mass spectrometer, where they are separated based on their mass-to-
charge ratio, (m/z) [71-80].  Figure 1.4 is a representation of an ICP-MS design.  In most 
cases, a quadrupole or magnetic sector mass analyzer is used to determine the m/z ratios 
of the ion abundance.  
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Figure 1.4 Schematic of inductively coupled plasma mass spectrometer.  
 
The use of ICP-MS offers several advantages.  It is rapid, and it allows 
simultaneous multi-element measurement at low detection (ppb or less for some 
elements).  In addition, ICP-MS also has relatively small matrix effects with a wide 
dynamic range (up to 5–6 orders of magnitude), a precision ranging from 0.5 to 5%.  
ICP-MS can be applied to gases, liquids, and solids [71-80].  However, this technique has 
a few problems related to spectral interferences. Also, the analysis of solid samples can 
be a challenge [72-74].  Such effects are more pronounced for the elements like calcium  
(Ca) and sulfur (S).  Therefore, the low limit of detection for elements like Ca, iron (Fe), 
and S are usually affected [80].  Table 1.5.1 is an illustration of typical limits of detection 
for different elements obtained in an ICP-MS analysis. Table 1.5.2 lists some examples 
of spectral overlap interferences encountered with ICP-MS [76].   
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 Table 1.5.1 Limits of detection* for some biologically relevant elements by the use of 
the most abundant isotope in ICP-MS [80] 
 
Analyte ICP-MS (ppb) 
Al 0.05 
As 0.01 
Ba 0.001 
Cd 0.005 
Ca 0.5 
Cu 0.005 
Cr 0.005 
Fe 0.1 
Pb 0.001 
Mg 0.05 
Hg 0.001 
K 0.5 
P 1.0 
Na 0.05 
S 50 
Zn 0.005 
* The limit of detection (LOD) is the lowest amount that can be detected with precision 
using a given method. 
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Table 1.5.2 Examples of spectral overlap interferences encountered with ICP-MS 
[74] 
 
 
Ion 
 
 
Mass 
 
Source 
 
Interferes with 
elements of interest 
 
Ar+ 
ArH+ 
Ar+2 
Ar2+ 
 
36,38,40 
37,39,41 
76,78,80 
18,19,20 
 
 
Plasma gas 
 
Ca S K 
K Cl 
Ge Se Kr 
O F 
 
ArO+ 
OH n+ 
O2Hn+ 
52,54,56 
16,17,18,19 
32,33,34 
 
Water 
Fe Cr 
O F 
S 
 
N+ 
NO+ 
N2+ 
14,15 
30,31,32,33 
28,29,30 
Nitric acid 
Matrix, traces 
in plasma gas 
N 
P S Si 
Si 
 
C+ 12,13 Traces in plasma gas C 
 
ArCl+ 
ClO+ 
CuCl+ 
75,77 
51,53 
98,100,102 
Hydrochloric  
acid matrix 
As Se 
V Cr 
Mo Ru Pd 
 
Ba2+ 
 
Th2+ 
U2+ 
2Mg+  
 
65,66,67,671/2,68 
681/2,69 
116 
119 
48,50,52 
 
If M+ present at high 
concentration 
Cu Zn Ga 
 
Cd Sn 
Sn 
Ti Ca V Cr 
Underlined mass numbers are the most abundant isotopes of the element. 
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Nuclear Magnetic Resonance 
Background 
The discovery and applications of NMR are marked by a number of very 
important events.  In 1924, Pauli demonstrated that nuclei have an angular momentum 
[81].  In the same period, Gerlach and Stern determined the nuclear magnetic moments 
using atomic beam measurement [82]. In 1938, Retri and colleagues observed the 
resonance effect of nuclei when electromagnetic radiation was applied [83].  In 1946, 
after several years of exploration, Block at Stanford University and Purcell at Harvard 
University reported the first 1H NMR in liquid--H2O and solid paraffin wax [84].  In 
1953, this work was rewarded with a Nobel Prize in Physics.  Although NMR theory is 
relatively complex, the development of the technique seems to be more promising. 
Since its discovery by Felix Bloch and Edward Purcell, NMR has progressed 
considerably [85-95].  For a number of years, proton NMR has been performed to 
determine the physical properties of liquid and solid samples [94].  At present, NMR 
experiments have been extended to a wide variety of nuclei due to the availability of 
more powerful FT methods. In an effort to increase the sensitivity of the technique to 
study biomolecular species, NMR methods, such as high resolution NMR and magic 
angle spinning NMR have been developed [95-97].   
Spin Properties 
NMR measurements involve the interactions of radiowaves and the spinning of 
precessing nuclei in a molecule [97,98].  Although the energy of radiowaves is small, the 
nuclear spin of atoms is still affected.  Each atom is characterized by its spin number or 
angular momentum (Table 1.6.1).  Even number of protons or neutrons result in a zero 
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spin number.  In comparison, an odd number of protons or neutrons result in a non-zero 
spin number.  For example, 12C has an atomic weight of 12 equivalent to the same 
number of protons and neutrons.  Thus, the net spin is zero, and so is the angular 
momentum.  The zero angular momentum of 12C is not amenable to NMR experiments.  
In contrast, the 13C has an even number of protons and an odd number of neutrons; 
therefore, its spin number is ½ (where in this case n=1).  Such a spin value allows 13C 
NMR to be performed.  Other ½ spin types of NMR include 1H-NMR, 31P-NMR, and 
19F-NMR. 
Table 1.6.1  Spin number of nuclei [97,98] 
Number of mass = atomic weight 
(Proton + Neutron) 
Atomic Number 
(Proton) 
Spin Number 
Odd Odd or Even 1/2 ,   3/2 , 5/2 
Even Even 0 
Even Odd 1, 2, 3 
 
Nuclei with a non-zero spin quantum number, I, behave like a small magnet with 
magnetic moment, µ , defined by the equation [90,91] 
                                                   
[ ]µ γ π= +h I I( )
/1
2
1 2
,        (1.4) 
where h is the Planck’s constant and is γ the magnetogyric ratio.  The projection of µ 
along the z-axis, µz, is given by 
µ γz m h= l / 2π   ,                                        (1.5) 
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where ml is the magnetic quantum number with the allowed values ranging from (I-
1)……0, (-I+1)….-I.  Overall 2I+1 represents the possible states of the nucleus.  In the 
absence of an applied magnetic field, ml is independent of the energy of the nucleus. 
However, the degeneracy is cancelled when an external field is applied, and the energies 
of the nuclei are given by [92] 
                                            ,                                      (1.6)  E B m Bz= − = −µ γ0 0 2l / π
π
where B0 is the applied magnetic field in the z-axis direction. 
At spin ½ the nuclei are associated with two states corresponding to ml = 1/2 and 
–1/2. The difference of energy between the two states is [90,91] 
f B0 0 2= γ /  ,                                                  (1.7) 
where f0  is the Larmor frequency which arises from the interaction of the spinning 
nucleus with the magnetic field causes the magnetic moment to precess at f0.  
Mode of NMR 
During the first 25 years of its discovery, NMR experiments were usually 
performed using the continuous wave CW method.  Currently; all modern NMR 
spectrometers operate in the pulse-FT mode.  The CW method consists of either 
sweeping the magnetic field while holding the radio frequency constant or vice-versa. On 
the other hand in FT-NMR, a short RF pulse is applied as a result of the magnetization, 
and Mxy becomes nonzero [90-99].  Mxy processes around the z-axis at f0 [90-99].  The 
nuclear magnetic moment precesses around Bo with no phase coherence.  Due to the 
population difference in energy states, there is a net-magnetization in the direction of Bo 
along the z-axis.  A nuclear induction signal from macroscopic magnetization in the 
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transverse (x,y) plain Mxy is detected using the pulse/FT spectrometer.  The value of Mxy 
is zero at equilibrium.   
In FT-NMR, a transient signal is induced by the precessing Mxy in a receiver coil 
called the free induction decay (FID), which is orthogonal to the directions of Bo.  Since 
the RF probe excites the nuclei over a wide frequency range, the FID illustrates the time 
domain signals from all the nuclei, which resonant in the given frequency range.  Then, 
the Fourier transform of FID gives the frequency domain spectrum.  In addition, 
multiple-pulse NMR was introduced in order to be able to manipulate the nuclear 
magnetization by RF pulses.  Such methods allow the measurement of spin-lattice (T1) 
and spin-spin (T2) relaxation times for each resonance [100].  In addition, multiple pulse 
sequences can be used to increase the range of NMR applications.   A diagram of an 
NMR spectrometer with its components is provided in Figure 1.5.  The main component 
of an FT-NMR spectrometer is a magnet in which the sample is inserted.  The receiver 
coil or transmitter surrounds the sample.  The coil supplies the electromagnetic energy, 
which is necessary for the spin to change its orientation.  The nuclei are excited using a 
pulse, which is provided by a controlled oscillator.  This excitation of the nuclei is the 
result of energy absorption.   Therefore, an amplified radiofrequency signal is induced.  
The signal is transmitted through a coil.  Then, the signal, called free induction decay 
(FID), is amplified and transmitted to the detector.  The detector computes the frequency 
difference between the two states of the nuclei.  Then, the Fourier transform program is 
applied to the output in order to give a frequency domain spectrum.   
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 Figure 1. 5 A schematic of an NMR spectrometer. 
Solid State NMR 
Solid state NMR is a non-destructive technique, which is used to determine the 
structures of molecules in the solid state.  Many theoretical aspects of liquid NMR remain 
applicable in solid state NMR.  Solid and semisolid state NMR delivers lower resolution 
spectra than liquid state NMR.  In solid state NMR, poor resolution and broadband are 
due to dipole-dipole interactions and chemical shift anisotropy [104].  For example the 
solid dipole-dipole interactions are static, and they are a major source of line broadening 
because the chemical shift anisotropic value is not averaged [104].   
The lack of resolution can be explained using quantum chemical theories [105].  
By considering the terms in the nuclear spin Hamiltonian, the cause of line broadening 
can be understood in the following equation [106]. 
                                                    ,                                            (1.8) H H H H Hcs j d q= + + +
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where Hcs,is the  chemical shift, Hj ,is the scalar spin coupling term, Hd,is the dipolar 
coupling, and Hq,is the quadrupolar Hamiltonian.  The values of each term in the nuclear 
spin Hamiltonian expression are reported in Table 1.7.1. 
Table 1.7.1  Nuclei spin Hamiltonian parameters [106] 
 
Sample 
 
Hcs 
 
 
Hj 
 
Hd 
 
Hq 
 
Liquid 
 
 
103-104 
 
10-102 
 
0 
 
0 
 
Solid 
 
 
103-104 
 
10-102 
 
2-104 
 
105-106 
 
Equation (1.8) contains 4 terms, and each of them depends on the magnitude of the 
dipole-dipole interactions in Hertz (Hz) for liquid and solids.  For small molecules in 
liquid, the dipolar (Hd) and the quadrupolar (Hq) terms vanish due to the rapid isotropic 
molecular motion. [106].  The dipolar Hamiltonian for proton spin can be expressed as 
[106] 
H
r i j
r r r I I I Id
i j
i j i z j z i j i z i z= − − −∑γ 2 2 21 3 3h , ( )(, , , , , , ) ,                   (1.9) 
where is the length of the internuclear vector,  is the spin operator, is the 
gyromagnetic ratio, and is the Planck’s constant 
ri j, I γ
h
r ri j, cos= θ  ,                                                                                   (1.10) 
where θ  is the angle between the inernuclear vector and B0.   
ri j,  from equation 1.10 can be substituted into the equation 1.9..   
 18 
H
r i j
I I I Id
i j
i j i j i z i z= − − −∑γ θ2 2 3 21 3 1 3h , ( cos )( ), , , ,
θ θ
1
                                          (1.11) 
In liquids, θ is the function of rapid, tumbled, and isotopic effects. The angular factor in 
equation 1.11 should be determined as [106] 
i j,
〈 − 〉 = −∫3 1 3 12 202cos ( cos ) sin, ,θ θπi j i j d ;                                                    (1.12) 
thus, . The quadrupole Hamiltonian has the same value as the dipolar 
Hamiltonian; therefore, the spectra of solutions will depend only on the chemical shift 
and scalar spin coupling Hamiltonian (H
〈 〉 =Hd 0
cs + HJ).  In contrast, in the solid state, the system 
is rigid.  As a result θ is fixed with respect to Hi j, o and Hd for two protons.  The Hd and Hq 
are larger than Hcs and Hj in the solid state because the motion is strongly anisotropic.  
Therefore, the averaged Hd is incomplete.  For both solids and semisolids the line is still 
broad.   
Line broadening occurs in solid sample due to restricted motions.  Thus, the 
dipolar couplings, D, are not fully averaged to zero, and have a time-averaged 
dependence shown in the equation [107,109] 
D rα θ− −3 23( cos ) ,                                                                                         (1.13)  
where r is the internuclear distance and θ  is the angle between the static field and the 
internuclear vector.  For solution samples where isotropically tumbling molecules occur, 
D is averaged to zero [106].  In other words, the molecules move freely, and dipolar 
couplings are not observed.  In contrast, when there are restricted motions, dipolar 
couplings are present, which enhance the broadening of the NMR resonance [106]. Line 
broadening is also due to sample heterogeneity like a liquid containing solid sample.   
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Magic Angle Spinning (MAS)   
Magic angle spinning has been applied in order to correct the line shape and to 
improve the resolution of the solid state NMR spectrum.  The line broadening from both 
dipolar couplings and susceptibility continuities can be corrected by quickly rotating the 
sample about the so-called magic angle θ = 54.7 o [107,109], so that the dipole-dipole 
term vanishes and the overall molecular motion becomes similar to the motion of the 
molecules in solution.  This magic angle spinning (MAS) has been used in solid samples 
in order to average the chemical shift anisotropy [107,109].  In solution, dipolar splitting 
and chemical shift anisotropy are reduced to zero due to the rapid isotropic motion and 
the tumbling effects.  As a result, the average orientation of the crystalline axes will be 
equivalent to the magic angle, which leads to sharp lines.  Therefore, sharp lines at the 
isotropic chemical shift are obtained. Thus, this technique provides an enhancement of 
the signal-to-noise ratio and greater information content.  The experimental setup of the 
sample probe with respect to the magnetic field is shown in Figure 1.6 where the sample 
is oriented with respect to the applied field at the magic angle. 
 
Figure 1.6 Magic angle spinning was performed by rotating at high speed.  Solid 
sample inclined at the magic angle of 54.7o to the static field. 
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 X-ray Spectroscopy 
X-rays are electromagnetic radiation, which are located between visible light and 
gamma rays in the electromagnetic spectrum [110-112].  X-rays are characterized by 
their relatively short wavelength ranging from 0.01 Å to 100 Å [110-112].  X-rays can be 
produced by converting the kinetic energy of charged particles into radiation resulting in 
a continuous spectrum.  In comparison, monochromic x-rays can be obtained when 
exciting atoms collide with fast moving electron.  These characteristic, monochromic 
lines are obtained when electrons from the higher shells descend to fill a hole in a lower 
shell.  The energies of the characteristic lines depend on the energies of the two atomic 
shells involved (higher and lower shell).  Electrons in the atoms are distributed in a 
succession of shells K, L, M, N, etc., which are labeled according to the decreasing 
energy, respectively.  For each element, each shell has specific edge energy [113-115].  
For example, K-edge energy corresponds to the energy, which is necessary to "knock” an 
electron out of the K shell.   
The study in this dissertation was focused on XANES of calcium at the K edge. 
The objective was to monitor the absorption coefficient when an electron was ejected 
from the inner most shell of the atoms.  This process produced information on the 
chemical environment of the calcium complex.  In addition, x-ray absorption 
spectroscopy was used to investigate the chemical forms of calcium deposits, and to 
compare the calcium XANES spectra with the spectra of model compounds, such as 
hydroxyapatite and fatty acid calcium salts. 
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X-ray Absorption Spectroscopy 
During the x-ray absorption experiment, x-rays are absorbed by an atom causing a 
core electron level from, K, L, or M shell to be ejected out of the atom into the continuum 
(Figure 1.7).  The atom is in the excited state, and has an empty electronic core hole.  
Then, a higher-level core electron fills the core hole causing a fluorescence or Auger 
electron emission.  Such processes occur in discrete quantities energy, which can be used 
to characterize the absorbing atom. 
 
Figure 1.7 Description of x-ray absorption process 
 
X-ray Absorption Near Edge Spectroscopy (XANES) 
Biological specimens containing calcium have been studied using x-ray 
absorption near edge spectroscopy. The technique has been widely applied in the 
characterization of calcium in human skull bone, tissues, teeth, and milk.  Peters et al. 
(2000) studied the structure of bone samples by the use of x-ray absorption spectroscopy, 
x-ray diffraction, and thermal analysis [117].  Kirtley et al. applied x-ray absorption 
spectroscopy to determine the nitrogen-chemical structures in DNA and related 
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molecules. [118,119].   The same authors assessed also the difference in the spectrum of 
the C=C bond in DNA from the bond in bovine serum albumin.  Sugiura et al. reported 
Phosphorus K-edge x-ray absorption spectra of calcium phosphate compounds [120, 121] 
Figure 1.8 is a diagram of an x-ray absorption experiment.  XANES requires a 
source of photon energy in the range of few keV.  In the best cases, synchrotron radiation 
is used as a light source.  XANES spectra were collected by the use of an x-ray beam 
emitted by the accelerated, relativistic particles in the storage ring traveling through a 
beam tube and slits into a monochromator.  Two parallel crystals were used to send a 
single wavelength that is carried to an ion chamber that allows monitoring of the 
absorption of the samples.  A second ion chamber located behind the sample measured 
the transmitted intensity.  Detectors can be simple devices, like the gas ionization 
chamber in which detection of the ions is accomplished through the ionization of Ar, N2, 
and CH4.  In addition, solid-state detectors such as, Ge solid state, scintillation counter, 
and photon diode can be used in fluorescence experiments [122]. 
 
Figure 1.8 X-ray absorption experimental set up. Synchrotron radiation is used as 
an x-ray source. 
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 The energy dependence of the x-ray absorption coefficient, µ(E), at or above the 
absorption edge of a selected element, µ, was measured.  The absorption coefficient, µ, 
depends on the x-ray beam intensity passing through the sample and the thickness of the 
specimen, as shown in the equation [116, 117] 
µ = (ρZ4)/AE3,                            (1.14) 
where ρ is the density of the element of interest in the sample, Z is the atomic number, A 
is the atomic mass, and E is the energy of the x-ray.  µ(E) can be determined using the 
transmission or fluorescence mode.   
In transmission mode, the absorption is measured based on the amount of light 
transmitted through the sample using the equations [116,117] 
dI Idx= − µ                                                                                             (1. 15) 
ln( )
I
I
x
0
= − µ                                            (1.16) 
where  and  are the incident and the transmitted x-ray intensities and  is the 
thickness of the sample. 
I0 I x
In fluorescence mode, the filling of the deep core hole is detected through the 
determination of the x–ray absorption coefficient that is given by 
µ ( ) ~E I
I0                                                                              
(1.17) 
X-ray Diffraction (XRD)  
X-ray diffraction (XRD) provides structural information from crystal or powder 
samples, in which the atomic constituents are periodically ordered [123,124].  X-ray 
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diffraction has been widely applied in the characterization of biomaterials [125-128].  
Diffraction patterns are obtained for each sample due to the interference of the radiation 
with the crystal lattice or powdered samples.  The diffraction pattern for any crystal 
depends on the distribution of the electron around the central atom, the thermal vibration 
of the central atom, the order of the atom in the unit cell, and the wavelength of incident 
monochromatic beam [123, 124].  
Under ideal circumstances, all the diffraction patterns are obtained under the 
Bragg condition.  The Bragg condition is met when the entire distance traveled by the x-
rays in the crystal, 2a, is equal to nλ, as shown in the equation 
n dλ = 2 sinθ ,                                                 (1.18) 
where  θ  is the  angle of incidence of the x-ray beam with the crystal, d is the distance 
between the crystal plans, n is the diffraction order, and λ is the wavelength of the x-ray 
beam.  Figure 1.9 is an illustration of an x-ray diffractometer.  When coherent x-rays are 
scattered by an ordered lattice, the crystal structure can be determined.  The x-ray tube 
has been commonly used as a source of monochromatic x-ray radiation of 8.4 keV. 
 
Figure 1.9  Schematic of an x-ray diffractometer. 
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Chromatography 
Chromatography is an analytical method that allows the separation of mixture of 
analytes as a result of their partitioning between the mobile phase and the stationary 
phase [129].  Tswett, a Russian botanist, first introduced the technique in 1906 [126].  
His objective was to separate and isolate green and yellow chloroplast pigments.  The 
separation was performed using a stationary phase of sucrose and a glass tube as a 
support column [130].  Since then, chromatography has continued to develop.  The 
specific chromatographic techniques of thin layer chromatography (TLC), high 
performance liquid chromatography (HPLC), and capillary electrochromatography (CEC) 
are discussed. 
Thin Layer Chromatography (TLC) 
TLC is a planar chromatographic method, which is used to identify or confirm the 
presence of biological markers in complex mixtures [133-136].  The stationary phase 
consists of a plate (glass, metal, or plastic) coated with a thin layer of a solid adsorbent 
(silica or alumina).  Initially, a spot of the sample is placed at the bottom of this plate. 
Then, the plate is dipped into a pool of the mobile phase in a closed glass cylinder 
(Figure 1.10).  The separation takes place when the mobile phase rises slowly with the 
sample via capillary force.  As the solvent diffuses, the sample mixture interacts with the 
mobile phase and the stationary phase.  The mobility of the components depends on the 
solubility in the mobile phase and the analyte adsorption properties.  When the mobile 
phase reaches the top of the plate, the plate is removed from the glass chamber and dried.  
The separation of the components is visualized using ultra violet light or staining 
methods.  The identification of analytes is based on the retardation factor (Rf) values.  
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The Rf value of the compound is the ratio of the distance traveled by the mobile phase to 
the distance run by the analytes on the plate.   
 
Figure 1.10 A schematic of a TLC system:  A.) The separation at to . B.) The 
separation over time. 
 
High Performance Liquid Chromatography (HPLC) 
In HPLC separation, the sample is injected into a packed column with an 
appropriate stationary phase [137-141].  Figure 1.11 is a representation of the different 
components of a HPLC system.  The separation mechanism is based on the partition of 
the analytes between the stationary phase and the mobile phase.  The elution of the 
analytes is driven by pressure.  The optimization of the separation is dependent on the 
stationary phase and the mobile phase composition [137-139].  HPLC experiments can be 
performed in either the isocratic mode or the gradient mode.  In the isocratic mode, the 
solvent composition is maintained constant during the time of the experiment, whereas, in 
the gradient mode the solvent composition is varied throughout the run [137-139].  In 
both cases, the analytes are identified by migration times and through a peak spiking 
procedure.   
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 Figure 1.11  A diagram of an HPLC system. 
 
The HPLC separation of most biological compounds has been performed using 
the reversed phase mode.  In such cases, the stationary phase is composed of a non-polar 
matrix (C8, C18), and the mobile phase is a polar solvent.  The mobile phase is usually a 
mixture of water and a polar organic modifier like methanol or acetonitrile [137-139].  In 
reversed phase-HPLC, separation is the result of hydrophobic interactions between the 
non-polar stationary phase and the hydrophobic group of the analytes.  Hydrophilic 
analytes interact less with the stationary phase.  Thus, they will elute faster.  In contrast, 
hydrophobic analytes will elute at much longer time.  Other types of stationary phases 
have been developed for specific compounds.  For example, ion-pairing reagents have 
been bonded to the stationary phase in the separation of proteins [140-141].   
Multiple detection techniques have been associated with HPLC.  The most 
common is the ultra-violet (UV) detector.  However, other detectors such as light 
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scattering, conductivity, Fourier transform infra-red (FTIR), laser induced fluorescent 
(LIF), mass spectrometry (MS), and nuclear magnetic resonance (NMR) have been used 
[142-146].  Among these combined techniques, HPLC-MS has become the most useful.   
Capillary Electrophoresis 
Capillary electrophoresis (CE) is an electrophoretic method where the analyte 
separation is based on the analyte in the presence of an applied electric field.  A 
schematic of a CE instrument is shown in Figure 1.12.  Both ends of the capillary are 
submerged in buffer vials where one end is the positive electrode, and the other end is the 
negative electrode.  Then, a high voltage (max. 30 kV) is applied across the two 
electrodes.  A small amount of sample at nanoliter level is injected at one end of the 
capillary and the sample migrates through the capillary.  The injected species will diffuse 
depending on the electroosmotic flow, which is caused by the deprotonation of the free 
silanol group on the wall of the silica capillary.  The positively charged counter-ions from 
the solution and the negatively charged ions at the capillary wall create a zeta potential, ζ, 
which causes the diffusion of the ions towards the cathode.  The process enables the 
separation of the molecules regardless of their charge.  The separation is optimized by 
controlling the analyte migration velocity.  The migration velocity, µ, of the analyte 
depends on the electrophoretic mobility, µe, and electrosmotic mobility, µeo, yields [149-
152]   
µ µ µ= +e eo .                                                      (1.19) 
Then, the migration time, t, of the analyte is given by 
t
l
E
lL
V
= =µ µ ,                                                                   (1.20) 
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where l is the length of the capillary to the detector, L is the total capillary length, V is the 
applied voltage, and E is the electric field.   
 
 Figure 1.12 A schematic of an CE system. 
 
The analytes in the capillary are detected using an UV or an LIF detector.  The 
advantages of CE reside in its high separation power, its low sample size, and its short 
analyses time [153-156].  CE is a powerful analytical technique, which permits high 
selectivity separation of complex mixtures.  In addition, CE can provide high sensitivity 
when coupled with mass spectrometry. 
Other forms of CE have also been developed for the separation of more specific 
types of analytes (neutral analytes, proteins, lipids).  Among those are capillary 
electrochromatography (CEC), micellar electrokinetic chromatography (MEKC), 
capillary gel elctrophoresis, and capillary isotacophoresis [157-159].  In this research, 
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CEC was used to characterize the cholesterol (esters) composition of the plaque.  CEC 
provided high separation efficiency of charged and neutral analytes.  In addition, high 
selectivity separation was obtained by the use of high concentrations of organic modifiers 
(methanol, acetonitrile, and tetrahydrofuran) [160].  In CEC, a column packed with silica 
particles (LC stationary phase) is used to perform the separation, as a result of the plug-
like flow driven by the application of a voltage.   
Mass Spectrometry  
Mass spectrometry (MS) is used on structural elucidation of biomolecules [161].  
When it is coupled with liquid chromatography (LC), the technique can provide 
molecular weight identification of biological compounds.  Techniques, such as 
electrospray ionization mass spectrometry (ESI-MS), atmospheric pressure chemical 
ionization (APCI), and matrix assisted laser desorption ionization mass spectrometry 
(MALDI-MS) have been used with success for structural information of organic and 
inorganic compounds [161-164].   
Electrospray Ionization Mass spectrometry (ESI-MS) 
In electrospray, the ionization process is obtained by use of an electric field.  
Charged droplets are formed at the exit of a capillary tube with a weak flux.  The electric 
field induces the accumulation of charged droplets located at the end of the capillary.  
Then, the charged droplets are exposed to nitrogen, leading to the droplets shrinking due 
to evaporation.  Finally, a quasi-molecular ion is released as a result of strong charge 
repulsions [161].  The ions that are formed from these processes are first selected by the 
mass analyzer, and then detected using an electron or photomultiplier detector. Figure 
1.13 shows a scheme of an ESI-MS ionization mechanism. 
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 Figure 1.13 Electrospray ionization mechanism. 
 
Atmospheric Pressure Chemical Ionization (APCI-MS) 
APCI-MS provides the ionization of labile and nonvolatile substances, so they can 
be measured in the mass spectrometer.  The ionization of the analyte molecules results 
from collision with discharge from a corona needle containing ion gas.   During the 
collisions, there is a loss of internal energy, which is accompanied by the interchange of a 
proton.  Therefore, the process is known as gas phase ionization process.  A consequence 
of the proton transfer is the ionization of the analytes.  This occurs when the proton 
affinity of the analytes is greater than that of the solvent.  Figure 1.14 is an illustration of 
the APCI-MS.   
APCI-MS offers some advantages over conventional methods, such as electron 
impact ionization mass spectrometry [163].  The strength of the technique is that there is 
no need to introduce the liquid flow directly into the vacuum chamber.  
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Figure 1.14 Atmospheric pressure chemical ionization. 
Time-Of-Flight Mass Spectrometer (TOF-MS) 
In TOF-MS, ions of different mass are accelerated using a uniform kinetic energy.  
The ions with different velocities will reach the detector at different times for a given 
distance.  The most common type of TOF-MS is the one that uses a pulsed ion source 
where a voltage pulse extracts the ions from the source.  Figure 1.15 is a design of a 
TOF-MS.   A potential gradient between A and B of the field free flight tube allows the 
ions to travel with a uniform kinetic energy, and to be separated based on their m/z ratio 
at the repeller C.  Finally the sorted ions are detected at D with photo-multiplier tube.  
The main concern for this set-up is the resolution.  However, the resolution can be 
optimized by increasing the ion flight time [164-166].   
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 Figure 1.15 A schematic representation of a TOF-MS. 
 
Scope of Dissertation 
Atherosclerotic plaque development is a dynamic process in which plaque 
formation is in equilibrium with liquid blood and solid deposits.  Although many studies 
have been performed, the process of this equilibrium with respect to the chemical 
composition of the deposits remains unclear.  In addition, the factors that affect the 
equilibrium are not well understood.  In order to better understand this equilibrium 
process, differences between bypass and coronary artery plaque deposits from the same 
heart were investigated.  Bypass plaque deposits are chemical materials, which 
accumulate after bypass surgery.  In contrast, native coronary artery deposits are 
associated with the materials that accumulate during the lifetime of the patient.  
Therefore, the chemical differences between the two plaques may imply changes in body 
metabolism in later life. Such changes may be related to factors, such as diet, lifestyle, 
and age.  Previous studies conducted by Robinson and Murungi (1992) indicated that 
calcium and phosphorus concentration in bypass were an order of magnitude higher than 
in the native artery [10].  The complexities of the deposits depend on the acuity of the 
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disease.  However, the effects of these components, and other factors that affect such 
equilibrium are not well understood.  Studies in this dissertation were performed by the 
use of inductively coupled plasma mass spectrometry (ICP-MS), x-ray absorption near 
edge spectroscopy (XANES), nuclear magnetic resonance (NMR) spectroscopy, x-ray 
diffraction (XRD), and chromatography. 
Elemental Analysis By Use Of Inductively Coupled Plasma Mass 
Spectrometry 
 
The objective of these studies was to compare the distribution of the minerals in 
native and bypass plaque deposits and to investigate the chemical forms of calcium in 
both native and bypass plaque deposits.  The ion metals (Ca, P, Mg, Zn, Cu, Cr, and Cr, 
F, and S, etc.) present in the plaque were characterized.  To determine the chemical form 
of calcium in comparison with hydroxyapatite (Ca10(PO4)6 (OH)2,), the molar ratios of Ca 
to P were calculated for each sample.  Then, this ratio was compared to the theoretical 
molar ratio of Ca to P in hydroxyapatite.  The differences between calcified samples and 
the atheroma deposits were established by comparing the molar ratios of Ca to P.  
Solid-State NMR 
Magic angle spinning solid state NMR was performed on the plaque deposits from 
native and bypass coronary arteries, and on cholesterol, homocysteine, and homocystine 
model compounds.  The method allowed the determination 1) of the chemical differences 
between the native and the bypass coronary plaque deposits and 2) the study of the 
interactions of calcium with homocysteine and cholesterol.  In the 13C NMR spectrum of 
calcium-homocysteine, the chemical shifts of the carboxylate, alkene or carbon attached to 
the sulfur were examined.  In addition, the contribution of the proteins in the plaque was 
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determined using the ratio of the carboxylic to the aliphatic peak areas in 13C NMR 
spectra.  
X-ray Spectroscopic Methods 
X-ray absorption, x-ray diffraction, and imaging (light microscopy, scanning 
electron microscopy and microtomography) techniques were used to examine the native 
and bypass coronary plaque deposits.  These techniques were used to determine the 
distribution of the calcium within the plaque.  In the early stage of the plaque formation 
calcium is distributed heterogeneously in the arterial walls.  X-ray absorption methods 
were used to localize the calcium deposits and to investigate their chemical forms. 
Ca K-edge XANE spectroscopy, light microscopy, and x-ray diffraction were 
performed on coronary plaque deposits, fatty acid calcium salts, and hydroxyapatite.   In 
addition, silver staining methods were used to localize, and to identify the forms of 
calcium in the deposits.  A comparison of the x-ray data of the deposits with model 
compounds allowed determination of the chemical forms of calcium in the calcified and 
atheroma plaques.  
Capillary Electrochromatographic (CEC) and High Performance Liquid 
Chromatrography –Atmospheric Pressure Chemical Ionization Mass 
Spectrometric (HPLC-APCI) Analysis 
 
The lipids from the native and bypass coronary artery deposits from the same 
heart were extracted using the Folch method liquid extraction procedure.  The chemical 
compositions were determined using HPLC, CEC, and TLC.  In addition, APCI-MS was 
used to confirm the presence of cholesterol and its esters in chromatograms of the crude 
extracts.   
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CHAPTER 2 
 
ELEMENTAL ANALYSIS OF PLAQUE DEPOSITS FROM HUMAN AORTA 
AND CORONARY ARTERIES   
 
Introduction 
  Previous studies in our laboratory showed that calcium and phosphorus 
concentration in bypass arteries were significantly higher than in native arteries [1].  
However, these samples were obtained from living heart bypasses that had complete 
obstructions.  These deposits were obtained by drilling the clogged arteries.  Due to the high 
risk of death, this medical operation is no longer practiced.   
Minerals play a vital role in the proper function of the cardiovascular systems. 
Potassium, Na, Ca, and Mg play an important role in conduction and contraction of muscles 
including those of the heart. Studies using rats have shown that Cu deficiency results in 
degradation of the smooth muscle of the arteries and formation of coronary aneurysms [1,2]. 
 A high Zn to Cu ratio results in hypercholesterolemia in a lot of animals [3,4].  Lead and Al 
have been implicated in some forms of heart diseases, especially hypertension.  Aluminum 
has been known to interfere with the metabolism of Ca and Mg [3-5].   Aluminum has been 
shown to play an important role in many other biological processes [6,7].  Aluminum may 
bind to phospholipids, which can cause the alteration of the lipid membrane of the arterial 
wall.  Lead is known to have high affinity for sulfurhydryl groups, and can interfere with 
membrane function.  Homocysteine has been associated with heart disease although its 
function is not known.  The presence of homocysteine should result in an elevated sulfur 
concentration.  Therefore, the sulfur concentrations as well as the concentrations of the other 
metals mentioned above were determined.  The sulfur concentration can be used as an 
estimation of the presence of homocysteine and its analogs in the plaque deposits. 
 
 47 
 According to many studies, the elemental composition of the plaque deposits and the 
nature of the coronary plaque deposits are related to the age of the patients [8,9].  However, 
there is little information on the concentration of minerals in these different types of plaque.  
The objective of this study was to determine the concentration of numerous elements in 
various type plaques, and to note differences and similarities found in the results. Such 
results may be used to establish a correlation with disease, ages, gender, and lifestyle, which 
can be used as predictor of further events.  
Experimental Section 
Sample Collection 
  Dr. Richard E. Tracy of Louisiana State University Health Sciences Center in New 
Orleans, LA, provided the coronary arteries and the aorta samples.  The plaque deposits were 
collected from the coronary arteries of unanimous cadavers for whom the cause of death was 
usually unknown.  The plaque was removed carefully to avoid contamination from the 
intima.  The deposits from each coronary artery were classified as soft or crystalline plaques. 
 The classification was based on the visual examination.  After their collection, the plaque 
deposits were placed in clean plastic vials, and stored in the freezer at –70 °C until analyzed.  
Sample Digestion 
  An amount of plaque was weighed (~ 50 mg).  It was placed in an acid cleaned 
beaker and 30 to 50 ml of concentrated nitric acid were added.  The solution was heated at 
low temperature (~40 °C) on a hot plate for 48 hours.  The volume was reduced to about 2 
ml and the resulting solution was transferred quantitatively into a 10 ml volumetric flask and 
diluted with distilled water.  Each sample was analyzed in duplicate.  A sample blank was 
prepared by reducing the 50 ml of nitric acid to 2 ml through heating, and by performing the 
dilution to 10 ml with distilled water.   
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Instrument 
 The sample solutions were analyzed for metals using inductively coupled plasma 
(ICP) model (Optima 3000) online with a quadrupole mass analyzer.  The limit of detection 
of the ICPMS methods of each element was given in Table 1.5.1 chapter I.  The elemental 
composition of each sample was determined after the analysis of the standard solutions.  
Calibration curves were developed using standards with various concentrations of metals of 
interest (Ca, P, S, Mg, K, Na, Cu, Pb, and Cr) run under the same conditions as the samples.  
The calibration curves were used to calculate the concentration of metals in the plaque 
samples. 
Results and Discussion 
Metal Concentrations 
The elemental compositions for the calcified and the atheroma plaques are shown in 
Tables 2.1 and 2.2.  The description for each sample is shown in the corresponding legend.  
Samples 11, 12, 13, and 14 were taken from one heart, and the samples 22, 23, 24, and 25 
were taken from another heart.  It can be seen from these samples that there is a variation in 
metal concentration within the same heart or aorta sample. 
In general, all the concentrations were at the mole/g level, except for Ca and P, 
which were at the mmole/g level in the calcified plaques.  These two elements were about an 
order of magnitude higher in concentrations in the calcified plaque than in the atheroma 
plaque.  The concentrations of sodium and magnesium were about an order of magnitude 
higher in the atheroma plaque than in the calcified plaque, albeit at significantly lower levels 
than the calcium and phosphorus concentrations.  The copper and sulfur concentrations were 
marginally higher in atheroma plaque than in calcified plaque.  However, no significant 
differences could be discerned for Zn, Fe, Al, Si, and Ba 
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Table 2.1. Concentration of minerals in calcified plaques (µmoles/g) 
 
Samples Ca P Na K Mg Zn Cu Ba Pb Fe Al Si S 
 
1 
 
 
2000 
 
1000 
 
10 
 
20 
 
30 
 
1.0 
 
0.03 
 
0.01 
 
0.2 
 
2.0 
 
0.1 
 
1.0 
 
50 
 
2 
 
 
5000 
 
2000 
 
20 
 
20 
 
80 
 
1.0 
 
0.02 
 
0.07 
 
0.4 
 
1.0 
 
0.3 
 
2.0 
 
50 
 
3 
 
 
2000 
 
2000 
 
20 
 
30 
 
60 
 
4.0 
 
0.02 
 
0.03 
 
0.3 
 
1.5 
 
0.1 
 
2.0 
 
50 
 
4 
 
 
4000 
 
3000 
 
30 
 
20 
 
10 
 
2.0 
 
0.03 
 
0.04 
 
0.5 
 
1.0 
 
0.9 
 
2.0 
 
50 
 
5 
 
 
3000 
 
1000 
 
60 
 
10 
 
50 
 
44 
 
0.03 
 
0.02 
 
* 
 
0.0 
 
0.1 
 
1.0 
 
50 
 
6 
 
 200 
 
200.0 
 
80 
 
30 
 
20 
 
2.0 
 
1.00 
 
0.02 
 
0.1 
 
0.0 
*  
0.2 
 
80 
 
7 
 
1000 
 
700.0 
 
20 
 
30 
 
30 
 
2.0 
 
0.03 
 
0.01 
 
* 
 
1.0 
 
* 
 
0.2 
 
40 
 
8 
 
 
5000 
 
2000 
 
20 
 
20 
 
80 
 
10 
 
0.03 
 
0.02 
 
0.2 
 
0.0 
 
* 
 
0.8 
 
50 
 
9 
 
 
1000 
 
1000 
 
10 
 
40 
 
30 
 
1.0 
 
0.01 
 
0.03 
 
0.2 
 
1.0 
 
0.1 
 
1.0 
 
50 
 
10 
 
 
1000 
 
1000 
 
10 
 
30 
 
30 
 
1.0 
 
0.01 
 
0.10 
 
0.01 
 
1.0 
 
2.0 
 
0.6 
 
40 
 
11 
 
 
6500 
 
4500 
 
25 
 
30 
 
40 
 
5.0 
 
0.03 
 
* 
 
0.01 
 
1.0 
 
* 
 
0.3 
 
70 
 
12 
 
 
3000 
 
2500 
 
20 
 
25 
 
35 
 
3.0 
 
0.04 
 
0.02 
 
* 
 
1.0 
 
0.1 
 
0.2 
 
60 
 
13 
 
 
2500 
 
1000 
 
20 
 
30 
 
45 
 
2.0 
 
0.02 
 
0.01 
 
* 
 
1.5 
 
0.2 
 
0.3 
 
65 
14 
 
2700 1500 30 35 50 6.0 0.05 0.02 * 2.0 0.2 0.1 60 
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Table 2.2.  Concentration of minerals in atheroma plaques (µmoles/g) 
 
 
Samples Ca P Na K Mg Zn Cu Ba Pb Fe Al Si S 
 
15 
 
400 
 
80.0 
 
200 
 
50 
 
5 
 
1.0 
 
0.1 
 
0.20 
 
0.10 
 
10 
 
12 
 
0.2 
 
100 
 
16 
 
60.0 
 
70.0 
 
200 
 
30 
 
6 
 
40 
 
0.1 
 
* 
 
0.01 
 
2.0 
 
0.4 
 
0.3 
 
80.0 
 
17 
 
10.0 
 
40.0 
 
90.0 
 
30 
 
2 
 
1.0 
 
0.1 
 
0.02 
 
0.01 
 
20 
 
1.2 
 
10 
 
50.0 
 
18 
 
10.0 
 
400 
 
100 
 
40 
 
4 
 
1.0 
 
0.3 
 
* 
 
0.01 
 
1.0 
 
* 
 
* 
 
10.0 
 
19 
 
10.0 
 
30.0 
 
90.0 
 
40 
 
3 
 
1.0 
 
0.8 
 
* 
 
0.01 
 
1.0 
 
* 
 
* 
 
10.0 
 
20 
 
1.00 
 
30.0 
 
90.0 
 
40 
 
4 
 
1.0 
 
0.3 
 
0.01 
 
0.01 
 
1.0 
 
* 
 
2.0 
 
50.0 
 
21 
 
3.00 
 
30.0 
 
40 
 
30 
 
2 
 
1.0 
 
0.8 
 
* 
 
0.01 
 
1.0 
 
0.3 
 
0.3 
 
30.0 
 
22 
 
7.5 
 
8.0 
 
100 
 
25 
 
5 
 
2.0 
 
0.1 
 
* 
 
0.1 
 
0.3 
 
* 
 
0.3 
 
50.0 
 
23 
 
6.0 
 
6.5 
 
85 
 
30 
 
4 
 
2.5 
 
0.1 
 
* 
 
* 
 
0.2 
 
* 
 
0.2 
 
45 
 
24 
 
7.0 
 
6.5 
 
90 
 
30 
 
6 
 
3 
 
0.2 
 
* 
 
* 
 
0.4 
 
* 
 
0.2 
 
65 
 
25 
 
9.0 
 
8.0 
 
95 
 
40 
 
3 
 
2 
 
0.4 
 
* 
 
* 
 
0.1 
 
* 
 
0.3 
 
60 
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Table 2.1-2.2a:  Footnotes for 2.1 and 2.2  
  
Sample ID Description Age and Gender 
1 Plaque from aorta  80 year old male 
2 Plaque from an aorta  80 year old male 
3 Plaque from an aorta 90 year old male 
4 Plaque from an aorta  70 year old male 
5 Plaque from a native coronary  70 year old male 
6 Plaque from a native coronary  70 year old male 
7 Plaque from a native aorta old  70 year old male 
8 Plaque from a bypass coronary artery 70 year male 
9  A mitral valve  70 year old white male 
10  A mitral valve  70 year old white male 
11 Plaque from aorta  55 year old male 
12 Plaque from aorta  55 year old male 
13 Plaque from aorta  55 year old male 
14 Plaque from aorta  55 year old male 
15 Plaque from an aorta  60 year old female 
16 Plaque from an aorta  70 year old female  
17 Plaque from an aorta  90 year old male  
18 Plaque from thoracic aorta  40 year old female 
19 Plaque from aorta  40 year old female with stroke 
20 Plaque from abdominal aorta  40 year old woman with stroke 
21 Lymphoma materials  40 year old woman. 
22 Plaque from an aorta with lesions  55 year old male  
23 Plaque from an aorta with lesions  55 year old male 
24 Plaque from an aorta with lesions  55 year old male 
25 Plaque from an aorta with lesions  55 year old male 
 
 The mineral concentrations were higher in the calcified plaques than in the atheroma 
plaques.  The calcium and phosphorus concentrations were at least an order of magnitude 
higher in calcified plaque than in atheroma plaque.  The sodium and magnesium 
concentrations were about an order of magnitude higher in soft plaque than in crystalline 
plaque.  Copper and sulfur levels were marginally higher in soft plaque than in calcified 
plaque.  In some samples, the lead concentrations were quite high in the calcified plaque, but 
not in the atheroma plaque.  The concentrations of the other metals (Zn, Fe, Al, Si, Ba) were 
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very low in concentration, and there were no discernable differences in their concentrations 
between calcified and atheroma plaques. 
In these studies most of the plaque samples collected from women were atheroma 
plaque. However, the majority of samples from men hearts were crystalline. This may have 
either been accidental or a characteristic of deposits in the different sexes.  The differences in 
composition between the physical form of atheroma and calcified plaques made the 
comparison of metal concentrations between samples from men and women impossible.   
Calcium to Phosphorus Ratio 
The molar concentrations of Ca and P in calcified and atheroma plaque are presented 
in Figures 2.1 and 2.2, respectively.  The expected molar ratio of Ca and P in hydroxyapatite 
is shown as a line in the figures.  In the calcified plaque, the Ca to P molar ratios are similar 
to that expected from hydroxyapatite (Figure 2.1).  In the atheroma plaque, the P 
concentrations were significantly higher relative to Ca indicating the possible presence of 
phospholipids, phosphoprotein, adenosine triphosphate, guanine triphosphate, and 
phosphocreatine. (Figure 2.2).  No conclusions could be drawn as to the chemical form of 
the Ca in this case. 
 The overall studies indicate a better correlation of calcium to phosphorus ratio in the 
hard plaque with hydroxyapatite than in the soft plaques.  In some samples, the relative 
concentrations of phosphorus to calcium were too high to be hydroxyapatite.  Thus, the 
phosphorus may be attached to organic molecules, and the calcium may complex with amino 
acid residues of protein, cholesterol, or phospholipids.   
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Figure 2.1 Calcium to phosphorus molar ratio in calcified plaque samples. 
 
Figure 2.2 Calcium to phosphorus molar ratio in atheroma plaque samples 
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Table 2.3 Concentration of minerals in native and bypass coronary plaque deposits 
(µmole/g) 
 
Samples Ca P Na K Mg Zn Cu Pb Fe Al Si S 
 
1 
 
 
180 
 
220 
 
109 
 
3 
 
 
22 
 
0.6 
 
0.04 
 
0.03 
 
0.2 
 
1.1 
 
0.6 
 
23 
 
2 
 
 
55 
 
71 
 
160 
 
9 
 
29 
 
0.2 
 
0.6 
 
0.004 
 
0.01 
 
1.0 
 
0.4 
 
50 
 
3 
 
200 
 
85 
 
80 
 
26 
 
16 
 
0.4 
 
0.02 
 
0.007 
 
1.0 
 
2.0 
 
0.2 
 
36 
 
4 
 
 
750 
 
763 
 
171 
 
61 
 
16 
 
1 
 
0.01 
 
0.001 
 
3.0 
 
4.0 
 
0.6 
 
82 
 
5 
 
 
5000 
 
180 
 
286 
 
30 
 
160 
 
0.3 
 
0.02 
 
0.001 
 
7 
 
1 
 
1 
 
80 
 
6 
 
85 
 
270 
 
293 
 
12 
 
13 
 
1 
 
0.06 
 
0.006 
 
3 
 
6 
 
0.5 
 
140 
 
7 
 
 
1720 
 
280 
 
120 
 
27 
 
25 
 
0.6 
 
0.06 
 
0.006 
 
1 
 
5 
 
0.9 
 
36 
8 
 
 
720 
 
102 
 
56 
 
15 
 
2 
 
1 
 
0.06 
 
0.003 
 
0.5 
 
3 
 
0.6 
 
24 
 
9 
 
 
700 
 
109 
 
400 
 
6 
 
5 
 
0.5 
 
0.03 
 
0.02 
 
0.4 
 
4 
 
2 
 
34 
 
10 
 
2.2 
 
380 
 
44 
 
8 
 
16 
 
0.3 
 
0.02 
 
0.4 
 
3 
 
0.7 
 
1 
 
52 
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Table 2.3a: Footnotes for 2.3 
 
Sample Description Age 
1 Native coronary artery  55 year old male 
2 Bypass coronary artery  55 year old male 
3 Native coronary artery 70 year old male 
4 Bypass coronary artery  70 year old male 
5 Native coronary artery  47 year old male 
6 Bypass coronary artery 47 year old male 
7 Native coronary artery 56 year old male 
8 Bypass coronary artery 56 year old male 
9 Native coronary artery 55 year old male 
10 Bypass coronary artery  55 year old male 
 
  The concentrations of the metals in the native and bypass coronary arteries were also 
determined using ICPMS.  The concentrations of the minerals present in the bypass and the 
native plaque deposits are shown in Tables 2.3. The overall distribution of metals in the 
native and the bypass coronary artery plaque deposits is very different. Calcium and P were 
high in the native coronary plaque deposits, and much lower in the bypass coronary plaque 
deposits. The Ca to P molar ratio was higher than 1.66. Therefore, the calcium deposits in 
the native deposits are associated with hydroxyapatite. The low Ca to P molar ratio in the 
bypass is due to the variably high concentration of the P in the bypass deposits.  These 
results might indicate that the deposits were not crystalline enough, and Ca was not in the 
hydroxyapatite form.  In addition, essential elements, such as Mg, Zn, and S were found in 
the native and bypass deposits.  The concentrations of Mg varied in the native and bypass 
deposits.  
Conclusion 
 The concentrations of minerals were found to be higher in the calcified plaque 
samples than in the atheroama plaques. The differences in concentration of Cu and S were 
also observed in the calcified and atheroama plaques.  It is not obvious whether or not the 
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high concentrations of Ca and P in the calcified plaques would affect the chemical form of 
calcium which was statistically estimated to be comparable to hydroxyapatite.  In contrast, 
the above argument is rejected in the atheroma plaques where in average Ca and P 
concentrations were lower in the atheroma plaques. 
 From the hydroxyapatite Ca to P molar ratios, the minerals in the crystalline plaque 
primarily exist in the form of hydroxyapatite.  However, the low mineral concentrations 
indicate that the major component of the calcified plaque is organic in nature.  In 
comparison, hydroxyapatite is present in the atheroma plaque, but much of the phosphorus is 
organic in nature. The organic phosphorus may be an important.  In contrast, calcium may 
play an equally important role at this and later stages.  Finally, the low sulfur levels indicated 
that homocysteine was not a major component. 
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CHAPTER 3 
 
CHARACTERIZATION OF NATIVE AND BYPASS CORONARY PLAQUE 
DEPOSITS BY USE OF SOLID STATE NMR 
 
Part I. Investigation of the Chemical Differences Between Native and Bypass 
Coronary Artery Plaques from the Same Heart Using Cross Polarization Magic 
Angle Spinning Nuclear Magnetic Resonance (CP/MAS-NMR) 
 
Introduction 
 The composittion of atherosclerotic plaque has been studied using a combination 
of methods, such as scanning electron microscopy, x-ray spectroscopy, thermal analysis, 
and chemical analysis [1-7].  Weinmann et al. described the use of infrared (IR) 
spectroscopy to determine cholesterol and cholesterol esters present in the plaque 
deposits [8,9].  The liquid-crystalline phases of carotid plaque deposits have been 
determined by use of high-resolution 13C nuclear magnetic resonance (NMR) 
spectroscopy and 13C CP/MAS-NMR [10-12].  Warschawski et al. performed similar 
studies using a combination of MAS-NMR spectroscopy and two-dimensional 
Heteronuclear Overhausser Effect Spectroscopy (HOESY) on lipid membranes [13,14]. 
In this dissertation, CP/MAS NMR was used to investigate chemical differences between 
deposits from native and bypass coronary arteries from the same heart. 
Experimental Section 
Sample Preparation 
Dr. Richard E. Tracy of the Department of Pathology of Louisiana State 
University Health Sciences Center in New Orleans provided the native and bypass 
coronary arteries. Both native and bypass coronary arteries were removed from the same 
heart of cadavers. The collected native coronary arteries were completely clogged 
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whereas, the deposits in the bypass varied.  After removal, the samples were kept frozen.  
For the NMR experiments, the arteries were opened longitudinally to expose the inside 
layers for the removal of the deposits.  After collection, the samples were ground using a 
mortar pestle to facilitate the packing of the sample in the NMR rotor. 
Experimental Conditions 
 The 13C and 1H CP/MAS spectra were acquired on a Chemagnetics Infinity 400 
MHz (9.4 T) NMR spectrometer.  The 13C chemical shift standard was the methyl 
resonance of hexamethylbenzene (δ = 17.35 ppm).  The proton radiofrequency (RF) 
power, at the spectrometer frequency of 400.059499 MHz, was set to a 4.25 µs 90° pulse 
for cross polarization.  The contact time was 100 µs.  The number of scans was 
approximately 1000 and the delay between pulses was 3 seconds.  Samples were spun in 
a 5 mm zirconium rotor with dry N2 at a rate of a 5 kHz at room temperature.  A spectral 
width of 50 kHz (20 µs dwell).  
Phosphorus-31 spectra with proton decoupling were acquired at room 
temperature.  The 31P chemical shift was set with external 85% H3PO4 at δ = 0 ppm.  The 
phosphorus RF power was set equivalent to a 10 µs 90° pulse.  Approximately 1000 
scans were acquired with a delay between pulses of 1.5 seconds.  A spectral width of 250 
kHz (4 µs dwell).  
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Results and Discussion 
 Carbon-31 CP/MAS NMR 
 Using 13C solid state NMR, the native and bypass coronary plaque deposits were 
examined.  Representative NMR spectra are shown in Figures 3.1 and 3.2.  The 13C 
NMR spectra were complex in the region (0-75 ppm) corresponding to the aliphatic 
group of the steroid backbone of cholesterol and cholesteryl esters [15,16].  But, the 
complexity was not due to this.  Rather it was doubtlessly due to the presence of 
hydrocarbon groups of the phospholipid, protein, and triglyceride contents of the plaque 
deposits. 
 
Table 3.1 Chemical shift of 13C NMR of main functional groups [16] 
Chemical Shift (ppm) Functional Group 
0-50 Aliphatic carbon 
10-20 S-CH3 
110-135 Aromatic 
55-65 αC of the amino acid 
105-130 Double bond 
170-180 Carboxylate 
  
  The unsaturated carbons in cholesterol and cholesteryl esters have signals located 
between 120 to 130 ppm.  The deposits from the native coronary arteries are usually 
firmer than those from the bypass arteries.  Such physical changes between deposits may 
change the peak shape at 25 ppm.  This signal was assigned to the chemical shift of 
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carbon of the methyl group in aliphatic side chain of cholesterol and cholesteryl esters, 
and may be restricted to motions due to the crystalline of the sample.  Therefore, in the 
crystalline deposits, the signal of the methyl group, which is adjacent to the aliphatic 
group of cholesterol backbone, remains broad.  Similar differences at ~55 ppm and 175 
ppm resonance chemical shift were observed.  The signal at 55 ppm was less enhanced in 
the deposit from the native artery than in the bypass, which could indicate a lower 
concentration of double bonds in the deposits from the native arteries than from the 
bypass arteries.   
 To examine the 13C NMR spectra of the plaques, the ratio of the carboxylate peak 
(~175 ppm) was compared to the total peak areas (0-75 ppm).  The results in the different 
plaque samples are shown in Table 3.2.  On average, the ratio was 1 to 5 suggesting that 
one carboxylate correlated with 5 other carbons.  This 1 to 5 ratio does not correspond to 
a cholesteryl ester area ratio where the ratio is about 1 to 40 (Table 3.3).  
 Previous studies have shown that the cholesterol and cholesterol esters 
composition constituted no more than 40% of these samples.  The high carboxylic group 
content must originate in the remaining 60% of the plaque indicating a ratio of 1 to 3 or 1 
to 4.  This strongly indicates the presence of large quantities of protein in the plaque.   
Phosphorus-31 CP/MAS-NMR 
The 31P CP/MAS-NMR spectra of hydroxyapatite and phosphotidylcholine were 
used to identify the resonance chemical shifts of the phosphorous components in the 
plaques.  The 31P CP/MAS-NMR spectra of the native and bypass coronary plaques 
obtained are shown in Figures 3.3 and 3.4.  Two well resolved phosphorus peaks from 
organic phosphorus (-0.6 ppm) and hydroxyapatite (2.6 ppm) were identified in the 
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bypass plaque samples and all other soft plaque deposits.  In contrast, only one 31P 
resonance peak was found in the crystalline plaque deposits, which corresponded to 
hydroxyapatite.  Since atherosclerosis is a progressive dynamic process, calcification may 
also be a progressive dynamic process.  However, it should be noted that the calcium and 
phosphorus concentrations are at the ppm level and cannot account for the overall 
crystallinity of the hard plaque.  It follows that the bulk of this crystalline material is 
organic in nature.  Furthermore, the crystalline material would be more physically stable 
than the soft amorphorus plaque. 
 
Figure 3.1 13C CP/MAS-NMR of native and bypass coronary plaque deposits from 
the same heart. 
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 Figure 3.2 13C CP/MAS-NMR of native and bypass coronary plaque deposits from 
the same heart. 
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Table 3.2. Ratio of the peak area of the main functional groups present in the plaque 
deposits in comparison with model compounds 
  
Samples  Area Ratio 
Carboxylic/ 
Aliphatic 13C NMR 
 
 Area Ratio 
Alkene/ 
Aliphatic 13C NMR 
 
Native 
  
0.20 
 
  
0.10 
 
Heart 1 
Bypass 
 
 0.10  0.09 
Native 
 
  
0.05 
  
0.02 
Heart 2 
Bypass 
 
 0.20  0.15 
Native 
 
 0.19  0.13 Heart 3 
Bypass 
 
 0.10  0.05 
Native 
 
 0.18  0.07 Heart 4 
Bypass 
 
 0.22  0.14 
Native 
 
 0.19  0.08 Heart 5 
Bypass 
 
 0.18  0.07 
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Table 3.3.  Ratio of the peak area of the main functional groups present in the 
reference standards  
 
 
Standard Samples 
 
 Area Ratio 
Carboxylic/ 
Aliphatic 13C NMR 
 Area Ratio 
Alkene/ 
Aliphatic 13C NMR 
 
Cholesteryl 
linoleate 
 
  
0.03 
  
0.20 
 
Cholesteryl oleate 
 
  
0.03 
  
0.10 
 
Cholesteryl 
palmitate 
 
  
0.03 
  
0.08 
 
Fatty acid 
(hexadecanoic 
acid ) 
 
  
0.01 
  
0.0 
 
Tryglyceride 
(Propane 1, 2, 3 
triyl tripalmitate 
 
  
0.06 
  
0.0 
Triglyceride 
(propane 1, 2, 3, 
triyl trimyrisate) 
 
 0.09  0.0 
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Figure 3.3 31P CP MAS  NMR of native and bypass coronary plaque deposits. 
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 Figure 3.4  31 P CP MAS NMR of native and bypass coronary plaque deposits from 
the same heart. 
 
Conclusion 
Magic angle spinning solid state NMR was successfully used to characterize the 
native and bypass plaque deposits from the same heart.  Results indicate that the 
composition of the deposits in the native and bypass arteries are different in some 
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respects, but vary widely in composition.  The large broad band on the 13C NMR at 175 
ppm indicates the presence of significant quantities of protein in all deposits.  
There appears to be more double bonds in the plaque in the bypass arteries than in 
the native arteries.  The phosphorus in the native arteries seems to be primarily in the 
form of hydroxyapatite, while the phosphorus in the bypass and other soft tissue is likely 
due to organic-phosphorus compounds. 
Part II.  Investigation of the Effects of Calcium and Homocysteine on Cholesterol by 
Use of Solid State 13C CP/MAS-NMR 
 
It has been shown that the presence of homocysteine in the blood is a flag for 
potential heart problems [17-20].  The function of homocysteine is not known, and the 
chemistry involved is not understood.  Since homocysteine is an amino acid that has an 
easily oxidized thiol group, it can damage the endothelium cell by generating reactive 
free radical oxygen species.  This process can promote clot formation, and homocysteine 
thiolactone can precipitate LDL. An increase of the interactions of LDL with 
endothelium cells leads to the formation of platelets aggregates [20].  Ca is present in 
coronary plaques and it is not known if homocysteine is present in the coronary plaque.  
However homocysteine is present in the blood at concentration ranging from 10 to 12 
µmol/L.  80% of the homocysteine in the plasma is protein bound and the remaining 20% 
are oxidized homocysteine, homocysteine-cysteine and free homocysteine [21]. The 
questions that arise are the following (1) do homocysteine and Ca interact with or without 
cholesterol, and (2) what is the implication in the plaque formation? 
To answer the above questions, the reactions between homocysteine, cholesterol, 
and Ca were studied chemically.  These experiments were conducted using 13C NMR on 
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homocysteine, cholesterol, and the mixtures of homocysteine with Ca, cholesterol with 
Ca and homocysteine with cholesterol and Ca.  The reactions were signified by changes 
in chemical shift or changes in the peak shape. 
Introduction 
The structures of homocysteine and its related sulfur containing amino acids are 
shown in Figure 3.5.  These amino acids are highly reactive due to the thiol group, which 
can be readily oxidized [22-25].  In the past, most research was focused on the 
autoxidation properties of homocysteine.  In comparison, few investigations examined 
the reactivity of homocysteine with metal complexes.  Homocysteine damages the 
endothelium cells. This, in turn, leads to injuries on the arterial walls. The ability of Ca to 
form a stable complex with homocysteine has not been demonstrated yet.  Recently, 
homocysteine has been associated with the risk of coronary diseases [25,26].  Future 
findings of the complexation of Ca with homocysteine and its analogs might help to 
explain the injuries and the healing process that take place in the coronary arteries.   
Over the years, some evidence of the coordination of calcium with amino acid 
was reported [27,28].  These studies tried to gain a clear understanding of tissue 
calcification.  Many research groups synthesized and characterized calcium amino acid 
complexes.  Most results indicated that the complexes were either dimers or chain like 
polymers [27,28].  Furthermore, the coordination of amino acids with Ca through the 
carbonyl group shows that calcium is linked to oxygen [29,30].  For example Tang et al., 
performed potentiometric measurements, which explained that the oxygen in the carbonyl 
group was involved in the coordination of calcium based upon the slight depression of the 
Ca2+amino acid titration curve [22].  Similar work was also conducted by Maeda et al., 
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using NMR spectra of 14N, 15N, and the 17O in the determination of the interactions of 
calcium with glycine, DL-alanine, and β-alanine.  They found that binding of calcium to 
both amino acids was established by progressively adding Ca2+ to an amino acid solution. 
While adding Ca2+ ions progressively, the evidence that Ca2+ was bound to both 
carboxylate groups within the complexes was determined based on further broadening of 
the NMR signals of the 14N and 17O nuclei [29-31].  Although no significant shift was 
observed, the authors concluded that Ca binds very weakly to the ligand.  Using Raman 
and Infrared spectroscopies, similar observations were observed about calcium 
complexing with the ligands.   
 
 
Figure 3.5 Chemical structures of homocysteine and its analogs. 
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Experimental Section 
 Chemicals 
Calcium chloride, homocysteine, and cysteine were purchased from Sigma-
Aldrich (St-Louis, MO).  Distilled water was obtained from the system provided by US 
Filter United State Filter Corporation.   
 Chemical Reaction 
Calcium chloride (ca. 1.0 M), salt, and homocysteine (ca. 0.2 M) in aqueous 
solution at pH=7.4 were allowed to react in inert conditions for 24 hours.  The precipitate 
was washed three times with distilled water and two times with pure ethanol. Then, the 
milky product was dried under a stream of nitrogen for 30 minutes.  The final product 
was stored in a sealed vial in the refrigerator until further analysis.  
Results and Discussion 
13C NMR Spectra of Calcium-Homocysteine 
 
The 13C NMR spectra of cholesterol, Ca-cholesterol, homocysteine, Ca-
homocysteine-cholesterol, and homocysteine-Ca complexes were reported.  The 13C 
NMR spectra of free homocysteine and calcium-homocysteine are shown in Figure 3.6.  
Upon addition of calcium, 13C NMR spectrum of Ca-homocysteine shows the chemical 
shifts of the carboxylate at 176 ppm, and the secondary carbon at 56 ppm.  The chemical 
shift ranging from 0 to 70 ppm indicates a major shift, in comparison with pure 
homocysteine.  The downfield shift is indicative of calcium homocysteine interactions via 
the sulfur and the carboxylic group.   There was no major carboxylic shift in the 13C Ca-
homcysteine solid-state NMR spectrum.  Perhaps Ca interacts weakly with homocysteine 
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at the carboxylic group. Possible rearrangement of the structural complex can also favor 
direct interactions of Ca with the sulfur group [22,23]. 
 
Figure 3. 6 13C CP/MAS-NMR of homocysteine and Ca-homocysteine complexes. 
 
The interactions of Ca with cholesterol with and without homocysteine were also 
studied.  Both precipitates were analyzed using solid state 13C NMR.  The spectra of the 
reaction products were compared with free cholesterol.  The active sites of free 
cholesterol were previously described using solid state 13C NMR (Figures 3.7-3.9).  In 
these spectra the chemical shifts of the carbon attached to the hydroxyl, the alkene, and 
the methyl groups were monitored.  The Ca-cholesterol NMR spectra indicated a shift of 
the alkene.  Hence, a change of the peak shape (120-130 ppm) was noticed.  The results 
 73
illustrated that the alkene group interacts with Ca.  The results imply that Ca may interact 
with cholesterol in the plaque.  Such interactions might initiate phase changes of the 
plaque.  In contrast, there were no major changes in the solid state 13C NMR of Ca-
cholesterol-homocysteine compared to the solid state 13C NMR of free homocysteine.  
The active role of Ca might be inhibited by the presence of homocysteine.   
 
Figure 3.7 Solid State 13C NMR spectra of Cholesterol/Ca precipitates. 
 
These preliminary results are very promising.   However, more studies needed to 
be performed in order to monitor the kinetics of the reaction of Ca-homocysteine-
cholesterol.  Due to the possible release of peroxide by homocysteine, the presence of 
oxidized cholesterol in the reaction products is expected.   
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Figure 3.8 Solid State 13C NMR of cholesterol/homocysteine precipitates. 
 
 
 
 
 
 
 
Figure 3.9  Solid State 13C NMR of cholesterol/Ca/Homocysteine precipitates. 
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Effect of calcium and homocysteine on cholesterol stability: a proton NMR case 
study 
 
Liquid 1H NMR was also performed on the reaction products. Slight chemical 
shifts of the proton attached to the alpha and the beta carbon were observed on the Ca-
homocysteine solution NMR.  The following cholesterol Figure 3.10 illustrates the 
proton active sites of the molecule.  The changes of the chemical shift of these protons 
were monitored when Ca was added to the homcysteine solution. The changes of the 
chemical shifts were reported in Table 3.4.  
 
Figure 3.10  Chemical structure of cholesterol.  The bullets represent the proton 
active sites of the molecule. 
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Table 3.4  Effects of calcium and homocysteine on cholesterol conformation 
 
 
Active sites 
Cholesterol 
 
1H NMR 
Cholesterol/Ca 
 
1H NMR 
Cholesterol/Hcy
 
1H NMR 
Cholesterol/Ca 
/Homocysteine 
1H NMR 
A 5.35 5.40/ 5.70 5.40 5.35 
B 3.50 3.50 3.60 3.40 
R 0.68 0.68 0.67 0.69 
 
 
The peaks in the 1H NMR spectrum of the cholesterol/Ca are broader than the 
peaks on the 1H NMR spectra of the cholesterol/homocysteine and 
cholesterol/Ca/homocysteine.  This observation leads to the conclusion that the 
interactions of Ca with cholesterol are much stronger than in the cases of 
cholesterol/Ca/homocysteine. 
Conclusion 
 
The 13C and 1H NMR spectra of Ca-homocysteine, Ca-cholesterol-homocysteine, 
and Ca-cholesterol reaction products were compared with the NMR spectra of cholesterol 
and homocysteine.  Observation of the spectrum of Ca-homocysteine suggests some 
differences in comparison with the free homocysteine NMR spectrum.  These changes 
are mainly observed for chemical shifts ranging from 0 to 75 ppm.  The presence of these 
extra resonance peaks is likely due to the formation of disulfite group, and their 
interactions with Ca.  A major chemical shift change was not observed at the resonance 
chemical shift of the carboxylic group when calcium was added to the free homocysteine 
solution.  However, the liquid 1H NMR of homocysteine and Ca-homocysteine revealed a 
slight proton chemical shift, as a result of adding Ca.  This data shows that Ca might 
contribute to the formation of these aggregates, although strong interactions between Ca 
and the free homocysteine may not exist.  The evidence of the formation of the disulfite 
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group may favor the presence of multiple carboxylic groups that increase the chance for 
Ca to bind. 
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CHAPTER 4 
 
CHARACTERIZATION OF NATIVE AND BYPASS HUMAN CORONARY 
ARTERY PLAQUE DEPOSITS BY USE OF X-RAY METHODS 
 
Part I. High Resolution Three-Dimensional Visualization and Characterization of 
Coronary Atherosclerosis in Vitro by Synchrotron Radiation X-ray 
Microtomography and Highly Localized X-ray Diffraction 
 
Introduction 
Recently, a number of imaging techniques have been used to image 
atherosclerosis either in vivo or in vitro, including magnetic resonance imaging [1-4], 
angiography [5-9], ultrasonography [10], computed tomography (CT) [11], electron beam 
tomography (EBT) [12], magnetic resonance angiography [13], etc.  The spatial 
resolution of most of these clinical imaging techniques is greater than 0.5 mm. Although 
they can identify and characterize complex atherosclerotic lesions, their resolutions are 
still not satisfactory for imaging the details of micron-sized plaque, such as coronary 
calcifications.  High resolution images of atherosclerosis is needed for research purpose, 
particularly for calcification studies. Calcification is correlated very intimately with 
atherosclerosis [14, 15].  A close correlation between the extent of coronary artery 
calcification and the burden of coronary artery diseases (CAD) has been confirmed [10, 
12].  Currently, EBT is the ״gold ״ standard for calcium detection in the coronary arteries.  
Its in-plane resolution is approximately 0.5 mm, with a slice thickness of about 3 mm.  
To our knowledge, most EBT images are in two-dimensional (2-D). Images of coronary 
artery calcifications at higher resolution and in three-dimensional (3-D) have not been   
reported yet.  
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In this dissertation, high-resolution 3-D visualization of coronary atherosclerosis 
by use of synchrotron radiation x-ray microtomography (SR-XMT) method is reported.  
Like conventional CT, the SR-XMT technique measures volumetric information, and it 
provides pictorial views of the internal and external structure of materials.  However, due 
to the low divergence of the x-ray beams produced by synchrotron radiation, x-ray 
microtomography can achieve approximately one thousand times better spatial resolution 
than that of conventional CT [16].  The in-plane pixel size in the present report was 13 
µm and the slice thickness in the reconstructed 3-D images was 13 µm.  In-situ x-ray 
diffraction (XRD) measurements were performed simultaneously by aperturing and 
localizing the x-ray beam onto the calcification in question.  The approach of combining 
high-resolution 3-D visualization and in-situ XRD represents a significant advance in 
visualizing and identifying atherosclerotic calcifications.  
Experimental Section 
The monochromatic XMT measurements were conducted in vitro [17] on human 
atherosclerotic arteries that were removed from three white males. Their ages were 51, 
55, and 70, denoted sample A (SA), sample B (SB), and sample C (SC), respectively 
[18].  From a series of radiograms taken at sample orientations in 0.25 degree increments, 
a tomogram was reconstructed in the interactive data language (IDL) programming 
environment (19) using a filtered back-projection algorithm [20].  The reconstructed 
slices provide the x-ray mass density at each point in a sample.  The reconstruction was 
performed using a fast Fourier Transform algorithm following a re-gridding from a polar 
to Cartesian coordinate system [20].  Typical reconstructed volumes involved 658 × 658 
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× 517 arrays. Further 3-D visualization and image analyses were done using IDL.  This 
research emphasized the visualization and characterization of calcified plaque. 
Results and Discussion 
The coronary arteries used in these experiments were completely or partially 
obstructed (Figures 4.1A and 4.1B).  For the native arteries, only the lumen of the 
sample SA was open throughout the 6.8 mm long segment.  The diameter of the lumen 
decreased monotonically from one end of the artery to the other by 57.5%.  Although this 
artery was not completely occluded like the others, it still had a large amount of 
clustering on the arterial wall.  Recent studies have shown that during plaque 
development, there is "remodeling" of the artery wall, which maintain the lumen size.  As 
atherosclerosis progresses, the "remodeling" is overcome by plaque development, and 
stenosis occurs. [3, 13].  Therefore, visualization of arterial wall is more important than 
that of lumen for the characterization of the atherosclerotic disease.  
Three types of plaque compositions were distinguished based on the brightness of 
the image. The low-density component was identified as lipid-rich deposits, while the 
medium density was fibrous plaque. The high mass density component was identified as 
calcified particles [10, 21].  These three phases were separately observed using the 
absorption profile (Figure 4.1C). The absorption of the fibrous plaque at 12.5 KeV x-ray 
energy was about 0.003 (twice as the fatty plaque).  The calcium deposit had a higher 
absorption, i.e. approximately 10 times higher than the fibrous plaque.  The cross section 
sequence images of the native arteries perpendicular to the z-, x-, and y-axis show the 
morphologies and the distributions of the plaque components in atherosclerotic arteries in 
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three different directions.  Some calcified plaques were separately distributed as small 
clusters, while others were large continuous pieces along the longitudinal direction (z-
axis).  The calcification density was greater at the edge of the interior (Figure 4.1C).  
The bypass arteries showed less calcification in amount and size. The volume ratios of 
calcification to artery wall of the three natural samples were 3.7 ± 0.2%, 6.0 ± 1.3%, and 
20 ± 3%, respectively.  The ratios for the bypass specimens were only 0.025 ± 0.004%, 
0.032 ± 0.007%, and 0.021 ± 0.002%, respectively [23].  These ratios were hundred times 
lower than in the native deposits.    
The high-density plaques were confirmed to be calcium deposits by in situ 
powder x-ray diffraction.  Figure 4.2 illustrates the x-ray diffraction patterns in the native 
and the bypass coronary arteries, respectively.  The calcifications in native arteries were 
more crystalline than those in the bypass arteries.  The equivalent 2θ scan diffraction 
patterns were obtained when the Debye-Scherrer rings were integrated (Figure 4.2C). 
(23).  Each ring or peak was indexed by diffraction features of hydroxyapatite (HAP), 
Ca10(PO4)6(OH)2, with a hexagonal configuration with lattice constants of a = 9.424 Å, c 
= 6.879 Å.  The fact that no single unknown peak was found indicates that the majority of 
the crystalline component of a calcified plaque was composed of HAP.  In addition, there 
was an amorphous phase that contributed to the broadening of the peaks.  Small HAP 
crystal depsoits were observed on the arterial walls when scanning electron microscopy 
(SEM) was used [25-28].  The crystals were reported to be 1-30 µm in diameter, and they 
were heterogeneously distributed.  The amorphous phase corresponds to the connective 
tissue that has a long-range periodic structure.  
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 Figure 4.1 Cross sectional image sequences along the three different directions.   
Sample A, B, and C were from the coronary arteries of a 51, 55 and 70 
year old white male, respectively.  The presence of calcium is indicated 
by the color.   Increasing concentration of calcium changes color from 
orange to yellow. 
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 Figure 4.2. Powder x-ray diffraction patterns of calcium deposits. In situ XRD 
patterns were acquired at the same beamline (17) by narrowing the 
synchrotron radiation x-ray beam. The incident monochromatic x-ray 
energy was 25 KeV, equivalent to 0.496 Å wavelength that is 3 times 
shorter than that of the frequently used Cu Kα radiation. (A) Debye-
Scherrer pattern of one calcium deposit in the SC native artery and (B) 
in the SB bypass artery.  
 
In the translucent images of native and bypass arteries shown in Figures 4.3A and 
B, the morphology, the size, and the distribution of the calcified tissues can be visualized 
intuitively.  A large amount of the calcifications in the native arteries are preferentially 
deposited along the longitudinal axes of the arteries, and they have cylinder like shapes  
(Figures 4.3C and D).  Only a few small calcifications were found in the bypass arteries. 
The data suggest that larger calcium accumulations occurred over a longer period of time.  
It was also observed that not all large calcifications had closed cylinder-like shapes.  On 
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the contrary, the calcifications confined by the artery wall had a curve-like shape (Figure 
4.3E).  
 
 
Figure 4.3 (A-E).  Visualization of calcification in coronary arteries.  
The x-ray absorption features of the calcium deposits in the native arteries are 
different from those in the bypass.  The mass densities of the calcified plaques in native 
arteries are much higher at the edge than in the interior (Figure 4.4A), whereas the 
highest attenuations occur in the centers of calcium deposits in the bypass specimens 
(Figure 4.4B).  This difference shows that the HAP crystals nucleated in the tissue matrix 
may develop or move towards the outer surface of the calcified tissue over time. This 
results in a more dense distribution or larger crystalline grains near the edges.  The 
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attenuation coefficients, µ, of the fatty and fibrous plaques are very close to those of the 
adipose and soft tissues (Table 4.1).  Assuming the calcified plaque is only composed of 
HAP crystals (neglecting the trace amount of metals Mg, Na and Fe [28] and connective 
tissue, the attenuation contribution fraction, x, of HAP crystals in the edge or interior of 
the calcifications was estimated by use of the equation 
 µmeasured = x ∗µHAP + (1-x) ∗ µtissue,  
the results are listed in Table 4.2.  The maximum attenuation coefficient is less than 1/3 
of the value of pure HAP, and the resulting percentages of HAP range from ~ 4 to ~ 22%.  
 
Figure 4.4 Experimentally measured linear attenuation coefficient of the calcified 
plaques. (A) In each native artery. The monochromatic energies are 13.5,   
12.5 and 11 keV for the SA, SB and SC arteries, respectively. (B) In each 
bypass artery. The x-ray energies are 12.5, 12.5 and 15 KeV for the SA, 
SB and SC, respectively. The calcified tissues in the native arteries were 
selected from the planar cross-sections of 340, 460 and 320, respectively, 
and 56, 62 and 480 slices from the bypass arteries (Fig. 4.1A).   
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Table 4.1 Attenuation coefficients µ in cm-1 for each component at various x-ray 
energies (29). The densities of HAP, soft tissue and adipose tissue are 3.14, 
1.0 and 0.95 g/cm3, respectively [29].  The values were taken from the 
website of National institute of standards and Technology. 
 
E (KeV) µHAP (cm-1)  µTissue (cm-1) µAdipose-tissue (cm-1) 
11 114.5 3.8 2.4 
12.5 76.7 2.6 1.7 
13.5 59.8 2.1 1.4 
15 45.2 1.6 1.0 
 
Table 4.2 Fitted contributions of HAP and soft tissue to the measured µ values in the 
calcified plaque.  
 
Contribution fraction 
(%) 
At the µaver in native artery 
SA         SB          SC 
At the µmax in bypass artery 
SA          SB          SC 
HAP 38           38           38 19           28           30 
Tissue 62          62            62 81          72           70 
 
Conclusion 
SR-XMT is a very competitive technique for the high resolution and 3-D 
visualization of atherosclerosis..  Complementary techniques, such as SEM and XRD, 
provided a complete characterization of atherosclerotic plaques. Although SEM has 
higher spatial resolution than SR-XMT, it has a small 2-D viewing field.   
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Part II. Characterization of Calcium Deposits in Human Atherosclerotic Plaques 
Using X-ray, X-ray Diffraction, Light Microscopy, and Staining Methods 
 
Introduction 
Atherosclerotic plaque can be calcified or amorphous, according to the high or 
low calcium content, respectively.  Although the terms calcified and atheroma plaques 
are used in the literature, other researchers refer to these as a fatty streak plaque or a 
plaque with lesion, respectively [30].  It should be noted that plaque deposits generally 
start with fatty streak, and they progress to form lesions.  The different morphologies of 
the plaque motivated the use of several techniques for the study of plaque deposits.  
Different spectroscopic and imaging techniques have been used in order to gain more 
insight on the co-localization of fatty components and calcium in the plaque.  Selective 
methods, such as tomography, magnetic resonance imaging, and histological studies have 
been performed to characterize calcification [31,32].  The use of high-resolution 
tomography method allowed distinction and quantification of the presence of calcium in 
clogged arteries [33].  Other methods include scanning electron and light microscopies, 
which were used to assess the structural features of the atherosclerotic plaques [34].   
Recently, Sarig et al. have successfully demonstrated the association of calcium 
apatite and cholesterol in atherosclerotic plaques utilizing confocal microscopy [35].  In 
this study, the determination of the cholesterol distribution within calcified media was 
conducted using a fluorescence staining method.  The fluorescence stain probe, filipin, 
has a high affinity for cholesterol and was able to show the location of cholesterol within 
hydroxyapatite. The study concluded that cholesterol was incorporated within the 
calcium-phosphate-cholesterol agglomerates.  It should be noted that these methods focus 
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on the localization of the mineralized plaque.  However, they cannot distinguish between 
the different possible chemical forms of calcium [34]. 
 In order to distinguish between homogeneous, heterogeneous, and ulcerated 
carotid plaques, Fourier Transform Infrared, Fourier Transform-Raman, and Near 
Infrared spectroscopic studies have been performed [36,37].  Although such vibrational 
analyses can provide more information regarding structures and morphology of the 
plaque deposits, the results are usually complex due to possible interferences from the 
sample matrix.  Another difficulty associated with these studies is the complexity and 
multiple steps required in sample preparations.  Therefore, alternative methods have to be 
considered. Wang et al. developed a magic angle spinning nuclear magnetic resonance 
method, with minimum interference to characterize the different phases of human 
endarterectomy plaques [38].  Based on the NMR chemical shifts, the latter study 
concluded that the spectral properties of the phosphate groups in carotid plaques were 
similar to those of hydroxyapatite in bone.  In earlier studies, chemical analysis prior to 
sample extraction, performed by Murungi and Robinson, highlighted substantial 
differences of calcium and phosphorus contents between “old” and “new” formed 
plaques.  The terms “old” and “new” were used to describe the plaque deposits in native 
and bypass arteries, respectively [39].   
The chemical form of the calcium during the progression of the plaque has not yet 
been thoroughly studied.  For example, it is not clear whether hydroxyapatite is formed 
during the initial formation of the plaque or if it appears only in the progressive form.  It 
is also not obvious that there are no other intermediates in the process of calcification.  
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Recently, x-ray synchrotron radiation spectroscopy has been applied in the investigation 
of the calcium forms in proteins [44].  Furthermore, studies on bone samples were 
performed using synchrotron x-ray absorption, x-ray diffraction, and thermal analysis.  
The results indicated that the sample’s mineral phase was mainly disordered calcium 
apatite with no evidence of calcium phosphate phase [44-46].  In fact, the latter studies 
cannot detect calcium phosphate, even if it were present in the sample.  However, 
different bone samples showed different carbonate content.  In addition, the size and the 
morphology of the bone mineral particles were not found to correlate with the type of the 
bone.  In addition, X-ray absorption near- edge structure (XANES) was used to determine 
the complexes of different metal ions [41,42].  In particular, XANES was used to 
determine the configuration of Ca-binding sites in calmodulin (CaM) [46].  The XANES 
results were shown to depend on the ketone and carboxylic functional groups in 
Calmodulin. 
 In this study x-ray methods, such as XANES and x-ray diffraction were used to 
study human coronary artery plaque.  In particular, the possible calcium forms in the 
plaque were examined.  Different chemical forms of calcium may also exist in the native 
and bypass plaque deposits.  Such differences might be due to the long life chemistry of 
the native coronary artery as compared to recent events in the bypass.  Therefore, the 
methods used in this study provide a powerful tool for examining the coronary plaques 
from native and bypass coronary arteries.  
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Experimental Section 
 Materials 
 Calcium oxide (CaO), calcium hydroxide (Ca(OH)2), and hydroxyapatite 
(Ca10(PO4)6(OH)2) were purchased from Sigma Chemical Co. (St. Louis, MO).  Stearic 
acid and palmitic acid calcium salts were obtained from Fluka (Milwaukee, WI).  The 
coronary plaques were donated by the Department of Pathology, Louisiana State 
University (LSU) Health Science Center, New Orleans, LA.  
Sample Preparation  
Segments (20 to 40 mm in length) from the right half of the thoracic to abdominal 
aorta and the left circumflex of the coronary arteries were collected from cadavers, and 
they were subjected to XANES analysis without further pretreatment.  The acquisition of 
the calcium XANES spectra was performed after exposing a segment of plaque wrapped 
with polypropylene (PP) film to the x-ray beam. 
For the x-ray diffraction experiments, the heart plaque samples were dried under a 
stream of nitrogen gas for 24 hours.  Then, the samples were ground into a fine powder 
using a mortar and pestle.  The plaque samples that were removed from the left 
circumflex arteries could not be transformed into fine powder due to their amorphous 
nature.  Thus, the x-ray diffraction analysis was limited to only crystalline samples.  
 Sample Processing for Light Microscopic Analysis 
The coronary artery plaque deposit sections were processed differently depending 
on the experiments (SEM or light microscopy).  Due to the complexity of the tissues, 
intensive sample preparation was required in order to obtain reliable results.  Initially, the 
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tissue components were preserved by fixation to avoid composition change.  For the 
purpose of electron microscopic techniques, the tissue was cut into thin slides.  Utilizing 
tissue samples cut with different thicknesses, the depth profiling, and the mapping of Ca 
were performed using electron microscopy.   
Cross section cuts of the coronary arteries were performed.  The performance of 
the shape of the slides was examined before and after their fixation.  Hence the results 
indicated that the slides were more regular and uniform when the samples were preserved 
prior to the cut.  After that the samples were embedded in a supportive media [48].  The 
light microscopy process required 4% formaldehyde (formalin) and paraffin as an 
embedding medium.  For scanning electron microscopy, the fixation process required 2% 
glutaraldehyde and epoxy as an embedding medium.  After fixation, the microscope 
slides were treated with silver nitrate.   
 XANES Spectroscopy 
 All experiments were performed at the Center for Advanced Microstructures and 
Devices (CAMD) Synchrotron radiation source at LSU, Baton Rouge, LA.  The XANES 
experiments were conducted using a beamline of x-ray light source operating at 1.3 GeV. 
X-ray beams are produced by the linear accelerator, and they travel through a slit before 
hitting the monochromator.  The XANES spectra were recorded in total electron yield 
(TEY) mode at a double monochromator (DCM) beam line that was equipped with Si 
(111) crystals.  The monochromatic crystal radiation in the region of interest was 
provided under the Bragg angle conditions.  The intensity of the incident radiation was 
measured using ionization chambers, containing 100 mbar helium.  Signals were detected 
 93 
using a Lytle detector.  The beamline was calibrated by the K-edge absorption that 
corresponds to the white line of CaO at 4043 eV.  XANES spectra of synthetic 
compounds were recorded in transmission mode at room temperature (25 
o
C).  The 
atherosclerotic plaques were recorded in fluorescence mode because of the limited 
amount of plaque samples.  Winxas software was used for data analysis [49].   
The XANES spectra were obtained by exposing the samples to monochromatic x-
ray beams ranging from 3993 eV to 4093 eV.  The absorption spectrum was monitored 
while scanning the monochromator.  Initially, a smooth baseline was observed when the 
x-ray energy was increasing.  This trend is continuous until an electron of the K shell is 
excited or ejected corresponding to an edge jump.  The edge jump described the 
transition of an electron from the ground state to the target with a vacancy in the 
absorbing atom.    The total absorption µ (k) above the absorption edge is given by [46]  
µ µ( ) ( )( ( ))k k x= +0 1 k , 
where (k) is the smoothly changing fraction of , which corresponds to the 
absorption coefficient of the isolated atom.  The fine structure is given by , which 
are the effects of the interference between backscattered and outgoing photoelectron 
signal in the photo-absorption matrix element. 
µ 0 µ ( )k
x k( )
 X-ray Powder Diffraction 
X-ray powder diffraction data was obtained using a Bruker Advance D8 powder 
diffractometer equipped with a focusing Ge (111) primary monochromator (CuKα1 
radiation).  Finely ground samples were placed on a zero background quartz sample 
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holder.  Intensity data was collected at ambient temperature in the 2θ range, between 10° 
and 80°, with a step width of 0.02°, and a 2 s count time.   
Results and Discussion 
 The Ca K edge x-ray absorption of calcium model compounds (Ca10(PO4)6(OH)2, 
fatty acid calcium salts, and calcium sulfide) was measured (Figure 4.5).  The results 
showed that the spectrum of hydroxyapatite was characterized by one K edge peak, and 
several weaker broad peaks.  Two points of inflection were present in the hydroxyapatite 
spectrum.  The features described the presence of structural disorder due to the lack of 
crystalline form of the hydroxyapatite sample.  The smooth edge of the spectra showed 
no inflection for the plaque samples.  A less intense white line with first and second order 
inflections was observed in Ca K edge XANES spectrum of hydroxyapatite.  Above the 
threshold, we observed shape resonances that resulted from multiple scattering in the 
calcium local environment.   The energy difference between the lower points of the edge 
to the maximum point of the shape resonance was calculated, in order to compare the 
differences in the XANES spectra between the plaque samples and standard calcium salt.  
Figure 4.6 illustrates the XANES spectra of the plaques and the model compounds.  
 
Figure 4.5 Ca K edge XANES spectra of model compounds. 
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The amplitude ratio of the shape resonance to the edge jump was determined.  
There were no major differences of )E (keV) between the plaque samples and the 
standard calcium salts, except for calcium sulfide, stearic acid, and levulinic acid calcium 
salts.   
 
Figure 4.6 Ca K-edge XANES spectra of plaques and model compounds. 
 
Structural studies using x-ray absorption fine structures (EXAFS) showed a 
difference between the plaque deposits and calcium salt model compounds.  The 
amplitude of the magnitude of the Fourier transform determined the radial distribution 
function of the neighboring atoms.  In the hydroxyapatite spectrum the distance of Ca to 
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oxygen was given by the location of the first shell.  A relative shift of the first 
coordination shell of the deposits to hydroxyapatite was observed.  The amplitude and the 
frequency of the Fourier transform EXAFS oscillations depended on the neighboring 
atom, and the distance between the core atom and the ligand.  Differences were observed 
in the higher coordination shell above 1Å in all the spectra.  This phenomenon was an 
indication of possible differences in sample crystallinity.  More crystalline samples tend 
to be more ordered (Figure 4.7).    
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Figure 4.7 Ca K edge EXAFS of coronary plaque deposits and hydroxyapatite. 
 
The combination of XANES and EXAFS allowed us to observe both short and 
long-range order, i.e differences between amorphous and crystalline materials.  
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Additional data using x-ray diffraction of the plaque deposit samples may give more 
details about the crystallinity of the deposits. 
X-ray microanalysis 
 Scanning electron microscopy on crystalline and atheroma (amorphous) deposits 
from native and bypass coronary plaques revealed irregular, rough, and amorphous 
surface features.  Simultaneous characterization using electron probe x-ray microanalysis 
provides elemental composition of highly calcified and amorphous deposits.  Qualitative 
differences were observed.  Calcium and phosphorus have the most intense signal in both 
plaque segments (Figure 4.8).  However, strong background interferences due to gold 
coating materials were observed. 
 
Figure 4.8 X-ray microprobe analysis of cross section cut of crystalline and 
atheroma deposits. 
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X-ray Diffraction Results 
X-ray powder diffraction analyses were performed on the crystalline samples 
from native and bypass coronary plaque deposits.  Figure 4.9A-B showed the diffraction 
patterns of the crystalline plaques and hydroxyapatite. Ca hydroxyapatite was used to 
assign the x-ray diffraction patterns of the plaque deposits.  The peaks on the x-ray 
diffraction of hydroxyapatite were accounted for the hexagonal space group P63/m, a = 
9.426 Å, c = 6.865 Å (JCPDS # 861203).   
 
Figure 4.9 A) X-ray diffraction of hydroxyapatite and plaque deposits from native 
and bypass coronary arteries of a 55 year old male. B) X-ray 
diffraction of hydroxyapatite and plaque deposits from native and 
bypass coronary arteries of an 70 years old male. 
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These results were in agreement with the published powder diffraction data [51].  
However, the broader peaks found on the x-ray spectra of the plaques were an indication 
of the amorphous form of the plaques. Therefore, x-ray diffraction method can be used to 
differentiate crystalline plaques from amorphous plaques.   
Histochemical and Histopathological Studies of Native and Bypass Coronary 
Arteries 
The silver staining method was performed on microscope slides with plaque 
deposits and calcium salts (hydroxyapatite, calcium sulfide, and stearic acid calcium 
salts), in order to study the distribution and the chemical forms of calcium on the arterial 
walls.  In this method the fixed slides were washed with silver nitrate reagent.  Then, the 
silver nitrate reacted with calcium deposits to yield a dark brown spot [48,52,53]. 
A metal substitution method, known as Von Kossa’s technique, was performed to 
characterize the calcium deposits in the native and bypass coronary plaque deposits.  In 
this method, calcium was replaced by silver and a metallic salt was formed with the 
anions of the calcium salt. The dark spots indicated the presence of the reduced silver.  
This revealed the location of the sites where calcium previously resided.  The following 
reaction mechanism describes the Ca displacement by Ag.  The effect of the Ca ligand in 
the results of the staining is not clear.  Therefore, different Ca salts were also treated with 
the Von Kossa silver stain. 
Ca 2+ CO3 2-   +   2[Ag+ + NO3-] Ag2 CO3   +  Ca 2+   2NO3-
2H +    +  Ag2 CO3 2Ag     +  H2O  + CO3
Reduction
by strong light  
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The Von Kossa technique was applied to the detection of calcium deposits, and 
the determination of their forms in native and bypass plaque deposits (Figure 4.10).  In 
Figure 4.11, the model compounds of Ca with silver stain are shown.  The data indicated 
that the stained native coronary plaque deposits show dark spots that were larger than 
those in the stained bypass coronary plaque.   
 
Figure 4.10 Microscope slides of native and bypass coronary arteies with no silver 
stains on the slides. 
 
Figure 4. 11 Stained calcium salts with silver nitrate. 
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Conclusion 
 The results indicated that the XANES Ca K edge spectra of plaque deposits 
followed similar trends.  A slight shift of the Ca K edge spectra of the deposits relative to 
that of hydroxyapatite was observed.  This shift might be due to a possible change in the 
Ca coordination.  The EXAFS results demonstrated differences between the native and 
the bypass plaque deposits.  In addition, the EXAFS Ca K edges exhibited differences in 
the spectra of the plaque and hydroxyapatite.  The differences were demonstrated by a 
shift of the first coordination shell in both spectra, which might be due to a change in the 
Ca environment.   
X-ray diffraction analysis indicated that only mineralized plaque deposits were 
able to provide diffraction patterns similar to hydroxyapatite.  However, this latest 
method failed to provide any information from the soft plaque, in which the forms of 
calcium could be mainly organic.  Furthermore, staining studies using Von Kossa method 
showed that the distribution of the calcium on the arterial walls was heterogeneous.  
Moreover, the staining method illustrated the formation of the large calcium aggregates 
in the crystalline deposits.   
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CHAPTER 5 
CHARACTERIZATION OF PLAQUE DEPOSITS USING CHROMATOGRAPHIC 
METHODS 
 
Part I. Capillary Electrochromatography of Cholesterol and Its Esters 
 
Introduction 
 
Cholesterol is one of the main components of cell membranes and has several 
functions in the body, including the synthesis of certain hormones such as vitamin D and bile 
acid.  However, too much cholesterol may be dangerous since it is believed that accumulation 
of cholesterol in the walls of arteries and veins accelerates the formation of atheroclerotic 
plaque and consequently inhibits blood transportation.  In the human body, this accumulation 
and inhibition of blood flow can be fatal by causing strokes and heart attacks [1-3].  Thus, 
accurate analytical tools for characterizing cholesterol are needed. 
Over the years, gas chromatography (GC) has been used to characterize cholesterol 
and its derivatives [4,5].  Usually, the GC analysis of a complex mixture of cholesterol 
derivatives provides poor resolution due to the structural similarity of these compounds.  
Therefore, capillary columns with high efficiency are necessary.  Fused silica coated with 
50% phenol and 50% dimethylsiloxane has been successfully tested to separate a mixture of 
eighteen cholesterol oxidation products [4].  However, baseline separation of all cholesterol 
derivatives were not obtained.  In general, GC and GC/MS methods have serious limitations 
including the need for thermally stable columns and cholesterol derivatization [6-8].   
Reversed phase HPLC with evaporative light scattering (ELS), refractive index, and 
electrochemical detection methods have also been reported for monitoring cholesterol 
derivatives [9-13].  Duncan et al.[11] performed the quantification of free, total, and esterified 
cholesterol extracted from human blood serum using HPLC.  Suarna et al.[14] characterized 
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the oxidized lipid products extracted from human artherosclerotic plaques using reversed-
phase HPLC, and quantified the α-tocopherol and ascorbate present in the extracted materials.  
These authors [15] also separated and characterized extracted cholesteryl, oxo- and hydroxy-
linoleate from human heart. The identification of extracted materials was achieved by 
performing semi-preparative HPLC, and then individual fractions were collected and analyzed 
by use of mass spectrometry with chemical ionization.  Murungi and Robinson [16] 
characterized cholesterol, cholesteryl arachidonate, palmitate, and stearate extracts from 
bypassed and non-bypassed heart plaque arteries using normal phase HPLC.  In comparison 
with the existing electrophoretic separation techniques such as capillary elecrophoresis (CE), 
HPLC has low column efficiency due to the need for pressure driven flow.  In addition, there 
are limitations due to UV-cutoff of organic solvent, which is often close to the λmax of 
cholesterol and its ester derivatives.  Although ELS or mass spectrometry detection could be 
employed to overcome this problem, the choice of mobile phase is limited and the solvent 
residues can still affect the signal-to noise ratio.   
To minimize solvent waste and improve the efficiency of the column, capillary 
electroseparation methods have been performed to analyze neutral and charged species.  
Micellar capillary electrophoresis (MCE) using sodium dodecyl sulfate (SDS) is a versatile 
technique that separates both charged and neutral species. To separate very hydrophobic 
neutral analytes, such as cholesterol esters, this technique does not appear to be a useful 
complement to HPLC.  This is because such analytes often bind strongly to the most 
commonly used micelles SDS and co-elute at the micelle migration time.  To minimize the 
strong interactions between SDS micelles and the cholesteryl esters, addition of organic 
solvents to the MCE buffer is one option.  However, the concentration of the organic modifier 
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that can be used is limited by stability of the micelle.  The addition of urea to the MCE buffer 
may reduce the binding of hydrophobic molecules (e.g. corticosteroids) to SDS, although this 
methodology may mask detection of cholesteryl esters at low wavelengths.  Nishi et al., use 
bile salts as another option for the separation of hydrophobic compounds [17].  However, 
experience in our laboratory indicates that the use of this surfactant results in significantly 
higher baseline noise at the low wavelengths which are required for detection of underivatized 
cholesterol.  Furthermore, recently microemulsion electrokinetic chromatography (MEEKC) 
appears to be a promising technique for the separation of highly hydrophobic compounds [18].  
However, selectivity of the technique appears to be limited due to band broadening.  In 
contrast, polymeric surfactants or micelle polymers, when used as a pseudo-stationary phase 
show high tolerance to organic solvent with high separation efficiency [19-21]. 
Capillary electrochromatography (CEC) is a hybrid technique, which combines the high 
efficiency of CE with the high selectivity of HPLC [22,23].  The separation mechanism in 
CEC is guided by the electrophoretic mobility of the solutes and their partitioning between the 
stationary phase and the mobile phase.  As a consequence, selectivity in CEC and HPLC is 
similar for neutral analytes.  However, for charged species, it combines the attractive features 
of electrophoretic and partitioning effects [24].  The technique continues to grow rapidly as 
evident by more and more applications developed in the last few years [25-28].  Zare et al. 
separated 15 of the 16 polycyclic aromatic hydrocarbons (PAHs) using CEC with an isocratic 
mobile phase [25].  Recently, Yan et al.[26] separated all 16 PAHs using an ACN/H2O 
gradient.  Similarly, corticosteroids in biofluids have been analyzed in less than 14 minutes 
using gradient elution [27].  In addition, triglycerides and free and derivatized fatty acids in 
fish oil have been separated using CEC [28].  Therefore, CEC is well suited for the analyses of 
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very hydrophobic compounds.  This is because unlike MCE, high levels (40-80% (v/v)) of 
organic solvents (acetonitrile, tetrahydrofuran and methanol) can be easily used in CEC to 
adjust selectivity.   
In this study, CEC is used to separate cholesterol and its ester derivatives.  Several 
chromatographic parameters such as buffer concentration, proportions of acetonitrile, 
tetrahydrofuran and water, voltage, and temperature were evaluated to optimize the CEC 
separation of a complex mixture of cholesterol derivatives with various chain lengths.  The 
possibility of combining CEC with EKC (using a polymeric surfactant) for improved 
resolution of cholesterol esters is presented.  To our knowledge, this is the first reported 
application of CEC for the analysis of cholesterol and its ester derivatives.   
Experimental Section 
Reagents 
Cholesterol (5-cholesten-3β-ol), cholesteryl acetate (5-cholesten-3β-ol 3-acetate), 
cholesteryl n-butyrate (5-cholesten-3β-ol 3-butyrate), cholesteryl n-valerate (5-cholesten-3β-
ol 3-pentanoate), cholesteryl n-hexanoate (5-cholesten-3β-ol 3-hexanoate), cholesteryl n-
heptanoate (5-cholesten-3β-ol 3-heptanoate), cholesteryl n-octanoate (5-cholesten-3β-ol 3-
octanoate), cholesteryl n-nonanoate (5-cholesten-3β-ol 3-nonanoate), cholesteryl n-decylate 
(5-cholesten-3β-ol 3-decanoate), cholesteryl palmitate (5-cholesten-3β-ol 3-palmitate), 
cholesteryl oleate (5-cholesten-3β-ol 3-oleate), cholesteryl linoleate (5-cholesten-3β-ol 3-
linoleate), cholesteryl laurate (5-cholesten-3β-ol 3-dodecanoate) and Tris[hydroxymethyl]-
amino-methane (Tris) were purchased from Sigma (St Louis, MO).  Tetrahydrofuran (THF) 
and acetonitrile (ACN) were obtained from Fisher (Springfield, NJ).  Trifluoroacetic acid 
(TFA) and hydrochloric acid (HCl) was purchased from Mallinckrodt (Paris, KY).  
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Sample Preparation  
Standards 
Stock solutions of each analyte were prepared at concentrations of ~10 mg/mL in THF.  
A 300 µL aliquot of each analyte was mixed and the solution was diluted with 1000 µL of a 
mixture (50:50) of THF and ACN.  The final concentration of each cholesteryl ester in a test 
mixture was ca. 0.60 mg/mL.  
Human Atherosclerostic Plaque 
 Plaque samples were obtained from the Pathology department of Louisiana State 
University Medical School.  The samples were collected from a 94-year old male cadaver.  
Because atherosclerotic plaques are potentially biohazardous, all glassware and cutting tools 
were carefully washed with a freshly prepared 10% Clorox solution.  Lipid contents were 
extracted from 1.20 g of wet specimen using a mixture of hexane/methanol/water (10:2:2 
v/v/v).  The hexane phase was separated and the solvent was evaporated under nitrogen.  The 
recovered dry lipid materials (Ca. 9.00 mg) were dissolved in 2 mL of mixture of THF and 
ACN for CEC analysis. 
Buffer Preparation 
Buffers of 5, 10, 15, 20, and 25 mM of Tris were prepared and the pH was adjusted to 
8.0 using 10 % TFA.  THF and ACN were added to the buffer and the final solution filtered 
using a polypropylene nylon filter with 0.45 µm pore size and sonicated for 10 min. 
Instrumentation 
Capillary electrochromatography (CEC) experiments were conducted using an HP 3DCE 
system (Hewlett-Parkard, Wilmington, DE).  Data were collected using ChemStation 
software.  The CEC columns (100 µm i.d. x 357 µm o.d. x 30 cm total length, 20 cm to the 
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detector) were packed with 3 µm Hypersil CEC C18 silica media according to the standard 
procedure described by Boughtflower et al.[29].  The electrochromatograms shown in Figure 
5.2 were obtained using a commercial C18 packed column (100 µm i.d. x 357 µm o.d. x 30 
cm total length, 20 cm to the detector) purchased from Unimicro Technologies, Inc. 
(Pleasanton, CA).  The packed capillary column was preconditioned by applying the potential 
in 5 kV increments for 10 minutes up to 25 kV.  In between injections, the CEC columns were 
conditioned for 5 min using 20 kV.  All sample solutions were injected electrokinetically (10 
kV, 3 sec.).  All CEC separations were performed using 12-bar pressure applied to both ends 
of the column to prevent bubble formation.  Unless stated otherwise (e.g., Figure 5.6), the 
capillary was kept at a constant temperature of 25 0C.  The elution of the analytes was 
recorded using a photodiode array detection system operated at three different wavelengths 
(200, 214, and 220 nm) with % RSD of approximately 5.00 for the migration time of 
cholesterol and its ester derivatives.  Since the best signal-to-noise ratio was observed at 200 
nm, this wavelength was used throughout the remainder of this study.   
Results and Discussion 
Cholesterol is a fat-soluble molecule.  It belongs to a class of biological compounds 
called sterols.  Like all alcohols, it forms esters with fatty acids.  Thus, the ester derivatives of 
cholesterol are obtained by replacing the proton of the OH group by a fatty acid backbone 
with a different chain length.  Figure 5.1 shows the chemical structures of cholesterol and the 
cholesteryl ester derivatives used in this study.  The influence of operating parameters such as 
type of acidic modifiers, organic solvent composition, buffer electrolyte concentration, 
temperature, and applied voltage were studied to optimize the CEC separation of these 
cholesterol esters.   
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CnH2n+1R = C17H31R =R = H
O
Cholesterol
Saturated cholesterol esters
n = 1-11, 15 Cholesterol linoleate
R
C17H33R =
Cholesterol oleate
 
Peak n Cholesterol ester derivatives 
1 - Cholesterol 
2 1 Cholesteryl acetate 
3 3 Cholesteryl butyrate 
4 4 Cholesteryl valerate 
5 5 Cholesteryl hexanoate 
6 6 Cholesteryl heptanoate 
7 7 Cholesteryl octanoate 
8 8 Cholesteryl nonanoate 
9 9 Cholesteryl decylate 
10 11 Cholesteryl laurate 
11 15 Cholesteryl palmitate 
12 - Cholesteryl oleate 
13 - Cholesteryl linoleate 
 
Figure 5.1 Chemical structures of cholesterol and twelve ester derivatives. 
Effects of Organic Modifiers. 
 
A stock solution of 25 mM Tris at pH 10 was prepared.  To avoid the risk of mixed 
retention and the dissolution of the silica bed, HCl and TFA were tested as acid modifiers to 
adjust the pH of the running buffer to 8.0.  Figure 5.2 compares the electropherograms for the 
separation of cholesterol derivative mixture using isocratic CEC with HCl and TFA as acid 
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modifiers.  Addition of HCl resulted in peak splitting and failed to prevent unwanted interaction 
between the stationary phase and the analytes (Figure 5.2A).  
 
Figure 5.2 Electropherograms of a mixture of cholesterol and twelve ester derivatives at pH 
8.0.  Using 25 % (v/v) THF/ 70 % (v/v) ACN /25 mM Tris.  The pH of the 
mobile phase was adjusted before the addition of the organic modifiers with (a) 
HCl and (b) TFA.  Conditions:  20 cm x 100 µm i.d. fused silica capillary 
packed with 3 µm ODS particles; 200 nm UV detection; 25 kV voltage, 
electrokinetic injection (10 kV for 3 sec).  The peak identification is listed in 
Figure 5.1. 
 
In contrast, when the pH of the Tris was adjusted with TFA, better peak shapes (absence 
of peak splitting) were observed (Figure 5.2B).  The background current was 23 µA and 14 µA 
using HCl and TFA, respectively.  It is possible that the peak splitting observed with the use of 
HCl may be due to joule heating cause by higher background current.  To improve peak shape 
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and resolution by suppressing interaction of the solutes with the silanol groups, all other CEC 
separation were performed with Tris buffers adjusted to pH 8.0 with TFA.  Cholesterol 
palmitate (11) and cholesterol oleate (12) did not elute even after 65 minutes.  Further 
optimization was performed to reduce the analysis time.  
Optimization of Mobile Phase Composition  
The effects of mobile phase composition were also investigated.  Solvent strength and 
solvent UV wavelength cutoff were considered in the separation of cholesterol and its 
cholesteryl esters.  It is well known that THF has higher elutropic strength than most solvents.  
It was found to be a good solvent candidate for fast, high efficiency separation of cholesterol 
derivatives.  In contrast, the UV cutoff for pure THF is around 214 nm.  This would likely 
increase the noise level and decrease the linear working range.  However, the addition of H2O 
and ACN decreases the relative background absorbance due to the dilution of pure THF.  In 
addition, the background effects of UV-absorbing solvents appear to be less critical in CE than 
in HPLC, probably because of the use of the shorter pathlength in CE [30].  Consequently, a 
series of experiments was conducted to optimize the CEC of 13 components of cholesterol 
derivatives using various volume fractions of THF and ACN at a constant pH 8.0, and buffer 
composition of 25 mM Tris.  Figure 5.3 shows the separation profiles of cholesterol and its 
ester derivatives using various percentages of THF and ACN.  Although cholesterol (peak 1) is 
less hydrophobic than the ester derivatives, it is more retained than the analytes 2, 3, 4, 5, and 6 
(Figure 5.3).  This suggests that cholesterol retention is likely governed by hydrogen binding 
interactions between the hydroxyl groups and the free silanols on the wall of the column.  
Therefore, cholesterol elutes as a result of polar and reversed-phase electrochromatographic 
interaction.  In contrast, the neutral ester derivatives of cholesterol elute from less to the more 
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hydrophobic.  Thus, the esters are separated based primarily on differential partitioning into the 
alkyl-bonded phase.  For example, cholesteryl oleate (12) and cholesteryl linoleate (13) each 
have 18 carbons on the ester side chain.  However, cholesteryl linoleate (13) is more 
hydrophilic (due to the presence of an extra double bond) and elutes before cholesteryl oleate 
(12).  As expected, migration time is reduced as a result of increasing THF concentration.  
Overall, the elution order is not solvent dependent.   
 
Figure 5.3 Effect of mobile phase composition on the CEC separation of cholesterol 
derivatives.  Conditions same as Figure 5.2 except TFA was used for pH 
adjustment, and mobile phase (THF/ACN) composition was varied. 
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When the volume ratio of THF was increased from 25% to 55% (v/v), the 
electroosmotic flow increased by 10%.  It is clear that an increase in the solvent strength (i.e. 
increasing THF concentration) decreases the total separation time at the expense of lower 
resolution and k’ values.  At 25% (v/v) THF/70 % (v/v) ACN, the total separation is very long 
and the last four cholesteryl derivatives (10, 11, 12, and 13) did not elute even after 80 
minutes.  Increasing the THF concentration to 35% (v/v) gives an elution window of about 70 
minutes from the electrosmotic flow marker to the elution of cholesteryl laurate (peak 11).  
All of the analytes elute in 20 minutes using 55% (v/v) THF.  However, cholesterol and the 
twelve-ester derivatives in the mixture are not well resolved.  Taking into consideration the 
resolution and speed of analysis, 35% (v/v) THF was used to further optimize separation 
conditions for the mixture of cholesteryl esters.  
Effect of Tris Concentration  
The effect of Tris concentration on the CEC separation of cholesterol and its ester 
derivatives was studied using 5 mM, 20, and 25 mM of Tris buffered at pH = 8.0.  As shown 
in Figure 5.4, both retention time and resolution of the analytes increase with increasing Tris 
concentration from 5-25 mM.  The increase in migration time is due to the interactions of Tris 
with the silica surface, which can alter the zeta potential, and thus reduce the electrosmotic 
mobility from 12.24 x 10-5 to 6.29 x 10-5 cm2 V-1 sec-1.  In general, resolution for most analytes 
increases with increasing Tris concentration due primarily to improved stacking during 
electrokinetic injection.  The use of even higher Tris concentration (>25 mM) was not feasible 
due to longer retention times, which in turn leads to band broadening.  Thus, a mobile phase 
of 25 mM Tris was chosen in all subsequent experiments. 
 117
  
   
   
 
Figure 5.4 Effect of Tris concentration on the CEC separation of a mixture of cholesterol 
and twelve ester derivatives.  Conditions same as Figure 5.2 except TFA was 
used for pH adjustment, Tris buffer concentration was varied, with 35 % (v/v) 
THF/ 60 % (v/v) ACN.   
 
Effect of Applied Voltage  
 The influence of the applied voltage on the efficiency, resolution, and the analysis time 
of the cholesterol esters were next evaluated using a mobile phase of 25 mM Tris in 35% (v/v) 
THF/60% (v/v) ACN/ 5 % (v/v) H2O at 25 0C.  As anticipated, a higher voltage reduced the 
retention times due to an increase in the net velocity from 27.2 mm/s at 25 kV to 52.5 mm/s at 
30 kV.  At 30 kV, the short chain esters and cholesterol elute faster with poor resolution.  In 
contrast at 15 kV, separation of the mixture takes longer with less efficient peak separation. 
Based on these results, the best resolution with higher efficiency was obtained using 25 kV 
(see Figure 5.5).   
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Figure 5.5 Effect of applied voltage on the CEC separation of a mixture of cholesterol and 
twelve ester derivatives using 30, 25 and 15 kV.  Conditions same as Figure 5.2 
except applied voltage was varied from 15 kV to 30 kV.  Mobile phase 
composition was 25 mM Tris, 35 % (v/v) THF/60 % (v/v) ACN/ 5% (v/v) H2O, 
(pH adjusted with TFA to 8.0).  
 
Temperature Studies  
An increase in temperature from of 20 to 60 0C was investigated in the CEC separation 
of cholesterol derivatives.  As shown in Figure 5.6, retention continues to decrease with an 
increase in temperature, whereas resolution between adjacent peaks first improves than 
deteriorates.  An increase in temperature from 20 to 60 0C at 25 kV resulted in a 50% 
reduction in analysis time due to an increase in electroosmotic velocity caused by lower 
electrolyte viscosity.  The peak resolutions significantly deteriorated at temperature > 40 0C.  
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Based on these results, a temperature greater than 40 0C was chosen as optimum since it 
produced baseline resolution of cholesterol and its ester derivatives in less than 40 minutes. 
 
Figure 5.6 Effect of temperature on the separation of a mixture of cholesterol and twelve 
ester derivatives.  Conditions same as in Figure 5.6 except 30 kV was used and 
the temperature was varied from 20 oC to 60 oC.   
 
Effect of Pseudo-Stationary Phase: Polymeric Sodium N-Undecanoyl-Glycinate   
It is now well documented that polymeric surfactants are stable even at high 
concentrations of organic solvent, whereas normal (unpolymerized) surfactants are not [17-
19].  To investigate the effect of the polymeric surfactant, poly-sodium N-undecanoyl-L-
glycinate (poly SUG), separation voltage (30 kV) and temperature (25 0C) were chosen for 
which the chromatographic resolution was relatively poor.  Electrochromatograms using 25 
mM Tris buffer with and without 5 mM of poly SUG at 30 kV are shown in Figure 5.7a and 
5.7b, respectively.  With no polymeric surfactant, the analytes are more retained because of 
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the hydrophobic interaction between the analytes and the hydrophobic chain of the stationary 
phase.  The addition of (poly SUG) affects migration time and peak resolution.  Shorter 
migration time and improved resolution were observed due to interactions between the 
polymer and the stationary phase, which in turn reduces the hydrophobic interactions of the 
analytes with the stationary phase.  In addition, critical peak pairs (peaks 3 and 4; peaks 1 and 
7) were baseline resolved.  Therefore, due to improve efficiency upon the addition of 
polymeric surfactant, the overall analysis time was reduced from 40 min to 35 min.  Further 
studies are underway to determine why only efficiency and not selectivity was influenced on 
the addition of polymeric surfactant.   
 
Figure 5.7 Effect of polymeric sodium N-undecanoyl-L-glycinate on the CEC separation of 
a mixture of cholesterol and twelve ester derivatives.  Conditions same as 
Figure 5.6 except separation was performed at 30 kV and 25 oC.  a) Tris buffer 
(25 mM, pH 8) /THF/ ACN (5:35:60 v/v).  b) Tris buffer (25 mM, pH 8) /THF/ 
ACN (5:35:60 v/v); with 5 mM polymeric sodium N-undecanoyl-L-glycinate.    
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CEC Separation of Crude Extracts From Human Atherosclerotic Plaques   
The samples involved in these CEC studies were mature plaques.  The origin of such 
plaques results from progressive alteration in the structures of the arterial walls [31].  Studies 
have revealed that in later years, atherosclerotic plaques contain complex lipid deposits, 
which are essentially large quantities of cholesterol and cholesterol esters.  To identify the 
lipid deposits, lipids extracted from plaque were removed from a segment of a human aorta 
and injected into the CEC capillary.  Figure 5.8 shows the presence of the cholesterol, 
cholesterol linoleate, and cholesterol oleate contents in the plaque samples.  As calculated 
based on peak area, the lipid extracts from the plaque sample contains 55% of cholesterol 
deposits with 20% cholesterol linoleate (13) and 24% cholesterol oleate (11).   
 
Figure 5.8 CEC separation of crude extracts from atherosclerotic plaque of a human aorta.  
Conditions are: Tris buffer (25 mM, pH 8) /THF/ ACN (5:35:60 v/v); with 5 
mM polymeric sodium N-undecanoyl-L-glycinate using a 25 cm x 100 µm i.d. 
fused silica capillary packed with 3 µm ODS particles; 200 nm UV detection; 30 
kV voltage, electrokinetic injection (15 kV for 6 sec). 
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Conclusion   
This work has fully demonstrated that CEC could be used to characterize cholesterol 
and cholesteryl esters extracted from atherosclerotic plaque deposits.  In the CEC separation 
the peak shapes of cholesterol derivatives were improved considerably when TFA was used as 
an additive to adjust the pH of the running buffer to eight.  Based on the poor solubility of the 
cholesterol esters, a running buffer with a high concentration of organic solvent (THF and 
ACN) was used as the mobile phase.  The use of the polymeric surfactant, in the CEC buffer 
decreased analysis time and improved resolution between two critical pairs of ester 
derivatives (3/4 and 1/7).  Thus, baseline resolution of the 13-component mixture of 
cholesterol was achieved with a separation time of less than 40 minutes with no need of prior 
derivatization.  Alternatively, in the absence of the polymeric surfactant, an increase in 
temperature to 40 0C provided baseline separation of the 13-component mixture on a similar 
time scale.  The optimized CEC method in the presence of the polymeric surfactant allows the 
characterization of cholesterol, cholesterol linoleate, and cholesterol oleate present in human 
aorta plaque. 
 
Part II.  Determination of Cholesterol and Its Esters in Plaque From Bypass and Native 
Arteries From the Same Human Hearts Using Liquid Chromatography/ Atmospheric 
Pressure Chemical Ionization Mass Spectrometry 
 
Introduction 
Many analytical methods have been used to study the composition of plaque deposits 
including gas chromatography coupled with mass spectrometry (GC-MS), high performance 
liquid chromatography (HPLC) to monitor the levels of cholesterol and related compounds in 
plasma, tissues and food [32-35].  HPLC methods have often been utilized as an alternative 
approach for the characterization of cholesterol and its ester derivatives [32-36].   Detection 
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methods, such as light scattering, refractive index, or ultra visible light have also been applied 
[37-40].  In each of these cases, the identification of the targeted analytes was determined using 
migration time and spiking methods.  In addition, mass spectrometry methods have been used to 
identify the myriad of compounds involved [40-47]. 
Earlier studies in our laboratory showed that the calcium and phosphorus concentrations 
in bypass deposits were significantly higher than in native artery deposits [16].  However, it 
should be noted that these samples were obtained from bypass arteries that had become 
completely occluded.  In contrast, current samples were obtained from cadavers and were often 
newly formed and different in texture. 
The objective of this research is to examine the cholesterol components of deposits in 
native and bypass deposits from the same heart and to note any differences.  Such results can be 
used to establish correlation between the cholesterol profile and the risk factors associated with 
atherosclerosis.  Therefore, quantitative determinations of cholesterol and cholesterol esters were 
performed by use of chromatography and mass spectrometry.  Attempts to use liquid 
chromatography coupled with electrospray mass spectrometry were unsuccessful because of the 
complexity of the spectra.  Atmospheric pressure chemical ionization mass spectrometry was 
therefore used as the detection system since it avoids the necessity of derivatization.  This 
technique was successfully applied in this study.  Large quantities of other compounds were 
shown to be present.  These have been qualitatively studied using 13C and 31P solid state NMR 
[49]. 
Due to the complexity of the mixture of the crude extracts, UV and APCI detection 
techniques were used to identify cholesterol and its esters in the plaque deposits.  Successful use 
of this method allowed a full characterization of cholesterol and its esters in the plaque deposits.  
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Experimental Section 
Reagents and Chemicals  
The standards of cholesterol, cholesteryl linoleate, cholesteryl oleate, cholesteryl 
palmitate, and stearate were purchased from Sigma (Milwaukee, WE) (Figure 5.9).  Isopropanol, 
acetonitrile, and formic acid were of HPLC grade and were obtained from Fisher Scientific 
(Pittsburgh, PA).  The human coronary plaque deposits were obtained through collaboration with 
Dr. Richard E. Tracey from the department of Pathology of Louisiana State Health Centers in 
New Orleans, LA. 
 
 
Figure 5. 9. Structures of cholesterol and its esters. 
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Sample Preparation 
Standards 
  Standard solutions of cholesterol, cholesteryl arachidonate, cholesteryl linoleate, 
cholesteryl oleate, and cholesteryl palmitate were prepared at concentrations of approximately 
1.0 mg/mL in a 50:50 mixture of isopropanol and acetonitrile.  
Atherosclerotic Plaque 
The plaque samples from native and bypass coronary arteries were collected from 
cadavers as listed in Table 5.1. The plaque deposits were obtained from the inner lining of an 
artery.  The sampling of the plaque was achieved by opening the arteries longitudinally and 
peeling off the calcified and the fatty materials located in the interior of the tunica intima [31,50].  
This study was to ascertain any differences in composition in bypass plaque (new) and native 
plaque (old).  Hence, the results may signify a change in body metabolism.  
Plaque Extraction. 
Approximately 0.1 – 0.2 g of samples were weighed.  The cholesterol and its ester 
derivatives were extracted with a mixture of chloroform/methanol/water (10:2:2 v/v/v) [51].  The 
chloroform phase was separated, and the solvent evaporated under nitrogen. The recovered dry 
lipid materials from the plaques (9.0 -5.0 mg) were dissolved in a 500 µL mixture (50:50) of 
isopropanol/ acetonitrile for LC/ APCI MS analysis. 
Instrumentation  
HPLC APCI-MS System.  
  The cholesterol and cholesteryl esters in the crude extracts from the plaque deposits were 
examined on a MarinerTM API-TOF Workstation from Applied Biosystems (Framingham, MA) 
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coupled to an HP 1100 HPLC system with an autosampler and an UV-VIS detector (Paolo Alto, 
CA).  The separation was achieved using a Bischoff ProntoSil C18 column, 120 Å, 3 µm, 100 x 
4.6 mm (Leonberg, Ger) with a solvent flow rate of 1 mL/min.  A mixture of 30% isopropanaol, 
70% acetonitrile, and 0.1% formic acid was used as the optimum eluent for separation of the 
mixture of cholesterol and cholesteryl ester derivatives considering a 10 µL injection size. 
 
Table 5.1. Source and description of the plaque deposits 
 
Plaque deposit 
 
Heart 
 
Sample 
 
 
 
Age 
 
 
 
Gender 
  
Description 
 
1 
  
70 
  
Male 
  
Native coronary artery 
 
2 
  
70 
  
Male 
  
Bypass coronary artery 
tied to the left 
circumflex 
 
3 
  
70 
  
Male 
  
Bypass coronary artery 
tied to the right 
coronary artery 
 
Heart 
1 
 
 
4 
  
70 
  
Male 
 
  
Bypass coronary artery 
 
5 
  
56 
 
  
Male 
  
Native anterior 
descendant coronary 
artery (highly calcified) 
 
6 
  
56 
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The Ionization process was achieved with the Turbo Spray TM probe at a temperature of 
400 °C at 4 kV.  Acquisition of the mass spectra was performed within a scan range of 100 to 
1000 Daltons with a scan rate of 1 spectrum per second.   The ion count threshold was set at 1.0. 
Results and Discussion 
Separation of Cholesterol and Cholesteryl Esters Mixture 
Optimum chromatographic resolution was obtained at room temperature using a mixture 
of 70% acetonitrile, 30% isopropanol, and 0.1% formic acid as the mobile phase at a flow rate of 
1.0 mL/min.  After the successful optimized separation of HPLC analysis of cholesterol and 
cholesteryl ester derivatives, calibration curves of cholesterol and cholesteryl ester were 
performed.  The data from standard mixtures are shown in Figure 5.10.    
 
Figure 5.10. Standard chromatogram of cholesterol and its esters using ultraviolet 
absorbance (λmax 200 nm).  Mobile phase was a mixture of 30%/ 70% 
isopropanol/ acetonitrile and Bischoff Prontosil C18 column, 120 Å, 3 µm, 100 
x 4.6 mm at flow rate 1 mL/m. 
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Calibration Standards 
Figure 5.11  illustrates the calibration curve for cholesterol. A consistent linearity was 
obtained from 0.2 mM to 1.5 mM for cholesterol and cholesteryl esters with linear regression (r2) 
coefficient   in the range of 0.99. 
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Figure 5.11 (A-D) Calibration curves of A) cholesterol,  B) cholesteryl linoleate, C) 
cholesteryl oleate,  D)  cholesteryl palmitate.  The conditions are 
described in Figure 5.2. 
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Characterization of the cholesterol and cholesteryl ester derivatives in plaque 
deposits by the use of HPLC-APCI-MS 
 
The APCI-MS results indicate that cholesterol and the cholesterol esters were present in 
the plaque deposits in native and bypass coronary arteries. Figures 5.12 and 5.13 represent the 
UV absorbance signals and the extracted ion chromatograms at m/z=369 of crude extracts from 
the coronary plaque deposits from native and bypass arteries of the same heart, respectively.  The 
ion fragment at m/z=369 corresponds to loss of water or the fatty acid side chain for free 
cholesterol or cholesteryl esters, respectively.  Figures 5.14A and 5.14B illustrate the proposed 
ionization mechanism of cholesterol and cholesteryl esters.  The presence of cholesterol and its 
esters in the crude extracts were confirmed using the retention times of the standard and the MS 
fragmentation pattern.    
The quantitation of cholesterol and its esters were obtained under identical conditions.  
The peak areas of cholesterol and cholesteryl esters were integrated to calculate the 
concentrations of cholesterol and its esters present in the crude extracts, and the results are 
shown in Table 5.2.  Cholesterol contributed as much as 34% and 32% in the native and bypass 
deposits, respectively.  In contrast, the total cholesteryl esters were detected as much as 23% in 
the native coronary arteries and 16% in the bypass arteries.   
The concentration of cholesterol was higher than the total concentrations of cholesteryl 
esters. The total concentrations were higher in the native coronary plaque deposits than in the 
bypass coronary plaque deposits.  The clogged deposits in the bypass coronary arteries were 
made of fibrous materials. Since the deposits in the native coronary artery occur over the life 
span of the individual, it is likely that much more complex and crystalline materials are present. 
These results were consistent with the values obtained for the analysis of the carotid plaques 
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using previous techniques such as nuclear magnetic resonance (NMR) and Near Infrared (NIR) 
spectroscopy [52, 53]. 
 
Figure 5. 12  A) UV trace of crude extracted from native coronary  plaque.  Mobile phase 
was a mixture of 30%/ 70% isopropanol/ acetonitrile and Bischoff 
Prontosil C18 column, 120 Å, 3 µm, 100 x 4.6 mm at flow rate 1 mL/min.  
Numerous compounds beside cholesterol and cholesteryl esters were 
detected.  B) Chromatogram of crude extracted from native coronary 
plaque deposits using m/z 369 as the detected fragment.  Only cholesterol 
and cholesteryl esters were detected using peak 369. 
 
 
 
 131
  
   
   
 
 
Figure 5.13 A) UV trace of crude extracted bypass coronary plaque deposits.  Mobile phase 
was a mixture of 30%/ 70% isopropanol/ acetonitrile and Bischoff Prontosil 
C18 column, 120 Å, 3 µm, 100 x 4.6 mm at flow rate 1 mL/min.  Numerous 
compounds beside cholesterol and cholesteryl esters were detected.  B) 
Chromatogram of crude extracted from bypass coronary plaque deposits 
using m/z 369 as the detected fragment.  Only cholesterol and cholesteryl 
esters were detected using peak 369. 
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Figure 5.14 Ionization mechanism of A) cholesterol and B) cholesteryl esters.  The 
ionization mechanism involved proton transfer. 
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Table 5.2 Weight percent of cholesterol and cholesteryl esters from coronary plaque 
deposits crude extracts 
 
Plaque deposits 
 
Heart   Sample    
 Cholesterol Cholesteryl 
linoleate 
Cholesteryl 
oleate 
 
Weight % 
Cholesteryl 
palmitate 
Cholesteryl 
stearate 
 
1 
  
11 ± 0.4 
 
5.1 ± 0.2 
 
0.5 ± 0.1 
 
13.0 ± 0.2 
 
5.0 ± 0.1 
 
 
2 
  
32 ± 1.0 
 
1.4 ± 0.1 
 
5.4 ± 0.4 
 
* 
 
* 
 
 
3 
 
  
6.0 ± 0.2 
 
2.0 ± 0.1 
 
2.0 ± 0.1 
 
2.0 ± 0.1 
 
0.8 ± 0.2 
 
Heart 
1 
 
4 
 
  
3.0 ± 0.1 
 
0.02 ± 0.01 
 
0.03 ± 0.01 
 
2.0 ± 0.1 
 
0.8 ± 0.2 
 
5 
  
18 ± 0.6 
 
0.8 ± 0.1 
 
1.0 ± 0.1 
 
* 
 
* 
 
 
6 
  
13 ± 0.5 
 
0.01 ± 0.01 
 
0.05 ± 0.01 
 
2.0 ± 0.1 
 
0.70 ± 0.2 
 
 
7 
 12 ± 0.5 5.0 ± 0.2 7.0 ± 0.5 3.0 ± 0.1 1.2 ± 0.2 
 
Heart 
2 
 
8 
  
6.0 ± 0.2 
 
2.0 ± 0.1 
 
3.0 ± 0.2 
 
* 
 
* 
 
 
9 
  
34 ± 2.0 
 
4.0 ± 0.1 
 
1.0 ± 0.1 
 
* 
 
* 
 
 
10 
  
10.0 ± 0.4 
 
0.8 ± 0.1 
 
0.2 ± 0.1 
 
6.0 ± 0.1 
 
2.5 ± 0.2 
 
 
Heart 
3 
 
11 
  
30 ± 1.0 
 
4.0 ± 0.1 
 
0.7 ± 0.1 
 
* 
 
* 
 
* Not detected. 
 
 134
  
   
   
Conclusion 
LC/APCI-MS analysis was successfully used to characterize native and bypass coronary 
plaque deposits. Fragmentation patterns and migration times were used to determine cholesterol 
and cholesteryl ester derivatives in the crude extracts from native and bypass coronary plaque 
deposits. Overall, the concentrations of cholesterol were arguably higher in the native arteries 
than in the bypass arteries. Surprisingly, the total concentration of cholesterol plus cholesteryl 
ester derivatives was less than 40% of the total plaque in all the samples analyzed. Also 
surprisingly, the cholesterol concentrations varied widely even within the same heart making 
conclusions difficult to reach.  Further, the concentration of the cholesterol was always higher 
than the total concentration of all the esters.  However, because of the small number of samples 
analyzed, caution must be taken in interpreting these results, which suggest further work to 
confirm the results here and a new study to identify the other 60% of the plaque. 
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CHAPTER 6 
 
CONCLUSIONS AND FUTURE STUDIES 
 
 Atherosclerosis is a disease caused by a blockage of the coronary arteries as a 
result of an accumulation of cholesterol (and its esters), proteins, and inorganic materials 
onto the arterial walls.  Bypass surgery, which has been one of the most efficient methods 
to cure the disease, remains very risky.  Furthermore, the bypass veins that are used to 
bypass the native artery generally fill with new deposits over few years.  Therefore, 
questions have been asked about the chemical differences between the two deposits, and 
the chemical forms of calcium in these deposits.  To answer these questions, a 
combination of analytical methods such as ICP-MS, solid state NMR, and 
chromatography were used to characterize calcified and atheroma (amorphous) plaques 
from native and bypass human coronary arteries from the same heart.  In chapter 2 the 
ICP-MS results indicated that the Ca/P ratio supported the view that the deposits existed 
primarily as hydroxyapatite in the crystalline plaque.  However, the low total 
concentrations indicated that the calcium deposits were not the major component of this 
plaque, which appears to be organic in nature.  The composition of the metal ions varied 
widely in the same heart.  Na and Mg were higher in the soft plaque than in the 
crystalline plaque, and Pb concentrations were higher in the crystalline deposits.  Zinc, 
Fe, Al, Si, Ba concentrations were very low.  The concentrations of Ca and P were in mg 
order of magnitude higher in the crystalline deposits than in the soft plaque.   
 In the atheroma plaque, some hydroxyapatite appears to be present, but much of 
the phosphorus is organic in nature, possibly phospholipids or phosphoproteins.  This 
may be important since the soft tissue appears to be the early form of the plaque, which 
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progresses to crystalline tissue over time.  The organic phosphorus may be an important 
component in the early formation of heart plaque.  By the same token, the calcium may 
play an equally important role at this and later stages. The low sulfur levels indicated that 
homocysteine may play a role in plaque formation, but is not a major component. 
In Chapter 3, Part I, cross polarization magic angle spinning NMR was applied 
in the characterization of the plaques from native and bypass arteries.  The solid state 13C 
CP-MAS NMR indicated that the signal from the carboxylic group was mainly due to the 
proteins and amino acid composition of the deposits.  In addition, 31P NMR showed that 
in the crystalline plaque only a single phosphorus resonance was observed which 
overlapped with the chemical shift of the phosphorus in hydroxyapatite.  Whereas, in the 
amorphous plaque, two main resonance peaks were observed. One correlates with the 
resonance chemical shift of phosphoorganic compounds and the other with 
hydroxyapatite.   
In Chapter 3, Part II, 13C CPMAS-NMR was also applied in the studies of the 
interactions of Ca with homocysteine, cholesterol, and homocysteine-cholesterol.  The 
13C NMR spectrum of homocysteine was compared to the 13C NMR spectra of 
cholesterol with and without Ca.   The results showed that the addition of calcium with 
cholesterol results in the resonance peaks of the alkene group being broader.  
Furthermore, the NMR of the Ca-homocysteine precipitate showed a shift of the carbon 
attached to the homocysteine sulfur group.  Also a shift was observed at the carboxylic 
group in comparison with free homocysteine.   
In Chapter 4, Part I, in vivo x-ray microtomography and x-ray diffraction were 
applied in the characterization of the crystalline and amorphous deposits from native and 
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bypass coronary arteries from the same heart.  SR-XMT was shown to be a very 
competitive technique in high resolution and 3D visualization of atherosclerosis in this 
study. Complementary techniques such as SEM and XRD, can help to provide a complete 
characterization of atherosclerotic plaques.  In Chapter 4, Part II, additional studies 
using x-ray absorption near edge structures indicated that the XANES spectra of deposits 
and hydroxyapatite have similar trends.  However, quick EXAFS analysis of the data 
showed differences between the deposits and the hydroxyapatite.  The results were able 
to provide the Ca coordination and the distances of Ca to the O.   
Solid-state studies using light microscopy in combination with silver staining 
method on the slides were performed on the native and bypass coronary plaque deposits.  
The results demonstrated that the color of the stains were comparable to the one obtained 
with fatty acid calcium salts.  In the bypass deposits Ca was evenly distributed, but in the 
native deposits high concentrations of Ca were found at the interface and in the arterial 
walls.   
Finally the use of CEC and HPLC-APCI MS in Chapter 5 allowed us to 
determine the concentrations of cholesterol and its esters present in the deposits.  First, 
the separation of a standard mixture of cholesterol and cholesteryl esters was optimized 
using isocratic capillary electrochromatograpy (CEC) and reversed phase high 
performance liquid chromatography (HPLC).  Then, the same methods were applied to 
measure the concentrations of cholesterol and its esters in the plaque. The concentrations 
of cholesterol were higher in the native artery than in the bypass artery.  The total 
concentrations of cholesterol varied widely and were less than 40% in the plaque.  
Furthermore cholesterol concentrations were higher than the total concentrations of 
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cholesteryl esters in the deposits.  The results showed that more materials (phospholipids, 
proteins, and amino acids) were involved in the accumulation of the plaque.   
Future Studies 
Few studies have demonstrated that other chemicals in addition to cholesterol are 
involved in the risks of coronary diseases [1,2].  One chemical that is associated with 
atherosclerosis is homocysteine.  It is thought that the complexation of homocysteine 
with Ca is a contributing factor leading to the formation of plaque deposits [3].  The 
results in Chapter 3, Part II, showed that Ca interacts with homocysteine and 
cholesterol.  However, specific chemical composition was not characterized.  Thus, 
further application using matrix assisted laser desorption mass spectrometry (MALDI-
MS) would determine the structure of the complexes [4].   
 
Figure 6.1 Proposed studies of the effects of homocysteine and calcium in plaque 
stability. 
The study of the effects of homocysteine in the oxidation of cholesterol was also 
proposed.  Through these studies the effects of Ca on the activity of homocysteine would 
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be determined.  The reaction products would be monitored by mass spectrometry and 
solid state NMR (Figure 6.1). 
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